<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2016-01-20" version="203">
<accession>P04062</accession>
<accession>A8K796</accession>
<accession>B7Z5G2</accession>
<accession>B7Z6S1</accession>
<accession>J3KQG4</accession>
<accession>J3KQK9</accession>
<accession>Q16545</accession>
<accession>Q4VX22</accession>
<accession>Q6I9R6</accession>
<accession>Q9UMJ8</accession>
<name>GLCM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glucosylceramidase</fullName>
<ecNumber>3.2.1.45</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Acid beta-glucosidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Alglucerase</fullName>
</alternativeName>
<alternativeName>
<fullName>Beta-glucocerebrosidase</fullName>
<shortName>Beta-GC</shortName>
</alternativeName>
<alternativeName>
<fullName>D-glucosyl-N-acylsphingosine glucohydrolase</fullName>
</alternativeName>
<alternativeName>
<fullName>Imiglucerase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GBA</name>
<name type="synonym">GC</name>
<name type="synonym">GLUC</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="7289" last="7293">
<title>Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.</title>
<authorList>
<person name="Sorge J."/>
<person name="West C."/>
<person name="Westwood B."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="3864160"/>
<dbReference type="DOI" id="10.1073/pnas.82.21.7289"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="50" last="53">
<title>Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.</title>
<authorList>
<person name="Tsuji S."/>
<person name="Choudary P.V."/>
<person name="Martin B.M."/>
<person name="Winfield S."/>
<person name="Barranger J.A."/>
<person name="Ginns E.I."/>
</authorList>
<dbReference type="PubMed" id="3001061"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)</scope>
<scope>VARIANT LEU-298</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Genomics" volume="4" first="87" last="96">
<title>The human glucocerebrosidase gene and pseudogene: structure and evolution.</title>
<authorList>
<person name="Horowitz M."/>
<person name="Wilder S."/>
<person name="Horowitz Z."/>
<person name="Reiner O."/>
<person name="Gelbart T."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="2914709"/>
<dbReference type="DOI" id="10.1016/0888-7543(89)90319-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1992" name="Genomics" volume="12" first="795" last="800">
<title>Polymorphisms in the human glucocerebrosidase gene.</title>
<authorList>
<person name="Beutler E."/>
<person name="West C."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="1572652"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90311-F"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Gene" volume="136" first="365" last="368">
<title>A novel transcript from a pseudogene for human glucocerebrosidase in non-Gaucher disease cells.</title>
<authorList>
<person name="Imai K."/>
<person name="Nakamura M."/>
<person name="Yamada M."/>
<person name="Asano A."/>
<person name="Yokoyama S."/>
<person name="Tsuji S."/>
<person name="Ginns E.I."/>
</authorList>
<dbReference type="PubMed" id="8294033"/>
<dbReference type="DOI" id="10.1016/0378-1119(93)90497-Q"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND 3)</scope>
<scope>VARIANTS GD ARG-223; GLY-230; PRO-235; ARG-241; ILE-252 AND ARG-364</scope>
<scope>VARIANTS GLY-310 AND HIS-368</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="1020" last="1026">
<title>Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease.</title>
<authorList>
<person name="Winfield S.L."/>
<person name="Tayebi N."/>
<person name="Martin B.M."/>
<person name="Ginns E.I."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="9331372"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG; 4 AND 5)</scope>
<scope>VARIANT MET-408</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1988" name="DNA" volume="7" first="107" last="116">
<title>Structural analysis of the human glucocerebrosidase genes.</title>
<authorList>
<person name="Reiner O."/>
<person name="Wigderson M."/>
<person name="Horowitz M."/>
</authorList>
<dbReference type="PubMed" id="3359914"/>
<dbReference type="DOI" id="10.1089/dna.1988.7.107"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-11</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1987" name="Am. J. Hum. Genet." volume="41" first="1016" last="1024">
<title>The human glucocerebrosidase gene has two functional ATG initiator codons.</title>
<authorList>
<person name="Sorge J.A."/>
<person name="West C."/>
<person name="Kuhl W."/>
<person name="Treger L."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="3687939"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1984" name="Fed. Proc." volume="43" first="1869" last="1869">
<title>Structural studies of human placental glucocerebrosidase.</title>
<authorList>
<person name="Martin B.M."/>
<person name="Murray G.J."/>
<person name="Coligan J.E."/>
<person name="Raum M."/>
<person name="Brady R.O."/>
<person name="Barranger J.A."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 40-44</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="123" first="574" last="580">
<title>Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system.</title>
<authorList>
<person name="Ginns E.I."/>
<person name="Choudary P.V."/>
<person name="Martin B.M."/>
<person name="Winfield S."/>
<person name="Stubblefield B."/>
<person name="Mayor J."/>
<person name="Merkle-Lehman D."/>
<person name="Murray G.J."/>
<person name="Bowers L.A."/>
<person name="Barranger J.A."/>
</authorList>
<dbReference type="PubMed" id="6091633"/>
<dbReference type="DOI" id="10.1016/0006-291X(84)90268-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 403-416</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="2349" last="2352">
<title>Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.</title>
<authorList>
<person name="Tsuji S."/>
<person name="Martin B.M."/>
<person name="Barranger J.A."/>
<person name="Stubblefield B.K."/>
<person name="LaMarca M.E."/>
<person name="Ginns E.I."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 409-462</scope>
<scope>VARIANT GD1 SER-409</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="1660" last="1664">
<title>Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.</title>
<authorList>
<person name="Dinur T."/>
<person name="Osiecki K.M."/>
<person name="Legler G."/>
<person name="Gatt S."/>
<person name="Desnick R.J."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="3456607"/>
<dbReference type="DOI" id="10.1073/pnas.83.6.1660"/>
</citation>
<scope>PROTEIN SEQUENCE OF 469-520</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="10975" last="10978">
<title>Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry.</title>
<authorList>
<person name="Miao S."/>
<person name="McCarter J.D."/>
<person name="Grace M.E."/>
<person name="Grabowski G.A."/>
<person name="Aebersold R."/>
<person name="Withers S.G."/>
</authorList>
<dbReference type="PubMed" id="7908905"/>
</citation>
<scope>MUTAGENESIS OF GLU-379</scope>
<scope>ACTIVE SITE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="FEBS Lett." volume="472" first="17" last="21">
<title>Further studies on the reconstitution of glucosylceramidase activity by Sap C and anionic phospholipids.</title>
<authorList>
<person name="Salvioli R."/>
<person name="Tatti M."/>
<person name="Ciaffoni F."/>
<person name="Vaccaro A.M."/>
</authorList>
<dbReference type="PubMed" id="10781797"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)01417-4"/>
</citation>
<scope>INTERACTION WITH SAPOSIN-C AND MEMBRANES CONTAINING ANIONIC PHOSPHOLIPIDS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-98; ASN-185 AND ASN-309</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Cell" volume="131" first="770" last="783">
<title>LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.</title>
<authorList>
<person name="Reczek D."/>
<person name="Schwake M."/>
<person name="Schroder J."/>
<person name="Hughes H."/>
<person name="Blanz J."/>
<person name="Jin X."/>
<person name="Brondyk W."/>
<person name="Van Patten S."/>
<person name="Edmunds T."/>
<person name="Saftig P."/>
</authorList>
<dbReference type="PubMed" id="18022370"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.10.018"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SCARB2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Traffic" volume="8" first="1676" last="1686">
<title>Integral and associated lysosomal membrane proteins.</title>
<authorList>
<person name="Schroeder B."/>
<person name="Wrocklage C."/>
<person name="Pan C."/>
<person name="Jaeger R."/>
<person name="Koesters B."/>
<person name="Schaefer H."/>
<person name="Elsaesser H.-P."/>
<person name="Mann M."/>
<person name="Hasilik A."/>
</authorList>
<dbReference type="PubMed" id="17897319"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2007.00643.x"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Brain" volume="132" first="1783" last="1794">
<title>Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.</title>
<authorList>
<person name="Neumann J."/>
<person name="Bras J."/>
<person name="Deas E."/>
<person name="O'Sullivan S.S."/>
<person name="Parkkinen L."/>
<person name="Lachmann R.H."/>
<person name="Li A."/>
<person name="Holton J."/>
<person name="Guerreiro R."/>
<person name="Paudel R."/>
<person name="Segarane B."/>
<person name="Singleton A."/>
<person name="Lees A."/>
<person name="Hardy J."/>
<person name="Houlden H."/>
<person name="Revesz T."/>
<person name="Wood N.W."/>
</authorList>
<dbReference type="PubMed" id="19286695"/>
<dbReference type="DOI" id="10.1093/brain/awp044"/>
</citation>
<scope>INVOLVEMENT IN PARKINSON DISEASE</scope>
<scope>VARIANTS GLU-46; CYS-170; GLU-232; GLN-296; SER-409; ALA-419; HIS-448; ASN-482; PRO-483; PRO-495; LEU-497 AND CYS-502</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98 AND ASN-309</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="EMBO Rep." volume="4" first="704" last="709">
<title>X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.</title>
<authorList>
<person name="Dvir H."/>
<person name="Harel M."/>
<person name="McCarthy A.A."/>
<person name="Toker L."/>
<person name="Silman I."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="12792654"/>
<dbReference type="DOI" id="10.1038/sj.embor.embor873"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 40-536</scope>
<scope>GLYCOSYLATION AT ASN-58</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="23815" last="23819">
<title>X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.</title>
<authorList>
<person name="Premkumar L."/>
<person name="Sawkar A.R."/>
<person name="Boldin-Adamsky S."/>
<person name="Toker L."/>
<person name="Silman I."/>
<person name="Kelly J.W."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="15817452"/>
<dbReference type="DOI" id="10.1074/jbc.M502799200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 40-536 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="4242" last="4253">
<title>Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.</title>
<authorList>
<person name="Liou B."/>
<person name="Kazimierczuk A."/>
<person name="Zhang M."/>
<person name="Scott C.R."/>
<person name="Hegde R.S."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="16293621"/>
<dbReference type="DOI" id="10.1074/jbc.M511110200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 40-536</scope>
<scope>CHARACTERIZATION OF VARIANTS GD SER-55; GLN-87; ASN-118; GLN-159; LEU-161; VAL-162; VAL-166; ASN-200; PHE-213; PHE-224; GLU-232; GLU-237; LEU-298; ILE-303; CYS-343; ILE-362; LYS-365; GLY-381; LYS-388; TRP-392; CYS-402; SER-409; VAL-410; HIS-419; LYS-421; ARG-429; LEU-433; SER-436; ASN-438; HIS-448; VAL-455; PRO-483; PRO-500 AND PRO-502</scope>
<scope>MUTAGENESIS OF CYS-43; CYS-57 AND CYS-62</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Acta Crystallogr. D" volume="62" first="1458" last="1465">
<title>Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease.</title>
<authorList>
<person name="Brumshtein B."/>
<person name="Wormald M.R."/>
<person name="Silman I."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="17139081"/>
<dbReference type="DOI" id="10.1107/S0907444906038303"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 40-536</scope>
<scope>GLYCOSYLATION AT ASN-58; ASN-98 AND ASN-185</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Nat. Chem. Biol." volume="3" first="101" last="107">
<title>Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.</title>
<authorList>
<person name="Lieberman R.L."/>
<person name="Wustman B.A."/>
<person name="Huertas P."/>
<person name="Powe A.C. Jr."/>
<person name="Pine C.W."/>
<person name="Khanna R."/>
<person name="Schlossmacher M.G."/>
<person name="Ringe D."/>
<person name="Petsko G.A."/>
</authorList>
<dbReference type="PubMed" id="17187079"/>
<dbReference type="DOI" id="10.1038/nchembio850"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 40-536 IN COMPLEXES WITH ISOFAGOMINE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="3" first="1" last="11">
<title>Mutations causing Gaucher disease.</title>
<authorList>
<person name="Horowitz M."/>
<person name="Zimran A."/>
</authorList>
<dbReference type="PubMed" id="8118460"/>
<dbReference type="DOI" id="10.1002/humu.1380030102"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="207" last="213">
<title>Glucocerebrosidase (Gaucher disease).</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8889578"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:3&lt;207::AID-HUMU2>3.3.CO;2-5"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1999" name="Mol. Genet. Metab." volume="68" first="209" last="219">
<title>Type 2 Gaucher disease: an expanding phenotype.</title>
<authorList>
<person name="Tayebi N."/>
<person name="Stone D.L."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10527671"/>
<dbReference type="DOI" id="10.1006/mgme.1999.2918"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="181" last="188">
<title>Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.</title>
<authorList>
<person name="Stone D.L."/>
<person name="Tayebi N."/>
<person name="Orvisky E."/>
<person name="Stubblefield B."/>
<person name="Madike V."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10649495"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200002)15:2&lt;181::AID-HUMU7>3.3.CO;2-J"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1990" name="Ann. Hum. Genet." volume="54" first="149" last="153">
<title>Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="1974409"/>
<dbReference type="DOI" id="10.1111/j.1469-1809.1990.tb00371.x"/>
</citation>
<scope>VARIANT GD TYR-255</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1990" name="DNA Cell Biol." volume="9" first="233" last="241">
<title>Sequence of two alleles responsible for Gaucher disease.</title>
<authorList>
<person name="Hong C.M."/>
<person name="Ohashi T."/>
<person name="Yu X.J."/>
<person name="Weiler S."/>
<person name="Barranger J.A."/>
</authorList>
<dbReference type="PubMed" id="1972019"/>
<dbReference type="DOI" id="10.1089/dna.1990.9.233"/>
</citation>
<scope>VARIANT GD CYS-502</scope>
<scope>CHARACTERIZATION OF VARIANT GD CYS-502</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1993" name="Genomics" volume="15" first="203" last="205">
<title>Identification of six new Gaucher disease mutations.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
<person name="West C."/>
</authorList>
<dbReference type="PubMed" id="8432537"/>
<dbReference type="DOI" id="10.1006/geno.1993.1035"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1994" name="Am. J. Med. Genet." volume="51" first="156" last="160">
<title>DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wei C."/>
<person name="Applegarth D.A."/>
<person name="McGillivray B.C."/>
</authorList>
<dbReference type="PubMed" id="7916532"/>
<dbReference type="DOI" id="10.1002/ajmg.1320510216"/>
</citation>
<scope>VARIANT GD HIS-535</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1994" name="Hum. Genet." volume="93" first="209" last="210">
<title>Two new Gaucher disease mutations.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8112750"/>
<dbReference type="DOI" id="10.1007/BF00210614"/>
</citation>
<scope>VARIANT GD ASN-438</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1994" name="Hum. Genet." volume="94" first="314" last="315">
<title>Y418C: a novel mutation in exon 9 of the glucocerebrosidase gene of a patient with Gaucher disease creates a new Bgl I site.</title>
<authorList>
<person name="Tuteja R."/>
<person name="Tuteja N."/>
<person name="Lilliu F."/>
<person name="Bembi B."/>
<person name="Galanello R."/>
<person name="Cao A."/>
<person name="Baralle F.E."/>
</authorList>
<dbReference type="PubMed" id="8076951"/>
<dbReference type="DOI" id="10.1007/BF00208292"/>
</citation>
<scope>VARIANTS GD SER-409 AND CYS-457</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1994" name="Mol. Med." volume="1" first="82" last="92">
<title>Glucocerebrosidase mutations in Gaucher disease.</title>
<authorList>
<person name="Beutler E."/>
<person name="Demina A."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8790604"/>
</citation>
<scope>VARIANTS GD ASP-215; THR-221; ARG-241; GLN-296; CYS-324; GLY-417 AND ASN-419</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="303" last="309">
<title>Gaucher disease in Spanish patients: analysis of eight mutations.</title>
<authorList>
<person name="Cormand B."/>
<person name="Vilageliu L."/>
<person name="Burguera J.M."/>
<person name="Balcells S."/>
<person name="Gonzalez-Duarte R."/>
<person name="Grinberg D."/>
<person name="Chabas A."/>
</authorList>
<dbReference type="PubMed" id="7627184"/>
<dbReference type="DOI" id="10.1002/humu.1380050406"/>
</citation>
<scope>VARIANTS GD SER-409; HIS-448; PRO-483 AND CYS-502</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="345" last="347">
<title>Identification of a new mutation (P178S) in an African-American patient with type 2 Gaucher disease.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wei C."/>
</authorList>
<dbReference type="PubMed" id="7627192"/>
<dbReference type="DOI" id="10.1002/humu.1380050414"/>
</citation>
<scope>VARIANT GD SER-217</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1996" name="Clin. Genet." volume="50" first="78" last="84">
<title>The molecular characterization of Gaucher disease in South Africa.</title>
<authorList>
<person name="Morar B."/>
<person name="Lane A.B."/>
</authorList>
<dbReference type="PubMed" id="8937765"/>
</citation>
<scope>VARIANTS GD SER-409; LEU-426; LEU-433 AND PRO-483</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="214" last="218">
<title>Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations.</title>
<authorList>
<person name="Kim J.-W."/>
<person name="Liou B.B."/>
<person name="Lai M.-Y."/>
<person name="Ponce E."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="8829654"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:3&lt;214::AID-HUMU5>3.0.CO;2-A"/>
</citation>
<scope>VARIANTS GD LEU-54; GLU-85 AND SER-227</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="272" last="274">
<title>Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients.</title>
<authorList>
<person name="Cormand B."/>
<person name="Vilageliu L."/>
<person name="Balcells S."/>
<person name="Gonzalez-Duatre R."/>
<person name="Chabas A."/>
<person name="Grinberg D."/>
</authorList>
<dbReference type="PubMed" id="8829663"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:3&lt;272::AID-HUMU14>3.3.CO;2-7"/>
</citation>
<scope>VARIANTS GD HIS-352 AND GLN-398</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="280" last="281">
<title>Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.</title>
<authorList>
<person name="Amaral O."/>
<person name="Pinto E."/>
<person name="Fortuna M."/>
<person name="Lacerda L."/>
<person name="Sa Miranda M.C."/>
</authorList>
<dbReference type="PubMed" id="8889591"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:3&lt;280::AID-HUMU15>3.3.CO;2-6"/>
</citation>
<scope>VARIANT GD1 THR-435</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1996" name="Neurology" volume="46" first="1102" last="1107">
<title>Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease.</title>
<authorList>
<person name="Seeman P.J.V."/>
<person name="Finckh U."/>
<person name="Hoeppner J."/>
<person name="Lakner V."/>
<person name="Liebisch I."/>
<person name="Grau G."/>
<person name="Rolfs A."/>
</authorList>
<dbReference type="PubMed" id="8780099"/>
<dbReference type="DOI" id="10.1212/WNL.46.4.1102"/>
</citation>
<scope>VARIANTS GD3 LEU-437 AND ILE-530</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1997" name="Am. J. Med. Genet." volume="70" first="437" last="443">
<title>Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses.</title>
<authorList>
<person name="Cormand B."/>
<person name="Grinberg D."/>
<person name="Gort L."/>
<person name="Fiumara A."/>
<person name="Barone R."/>
<person name="Vilageliu L."/>
<person name="Chabas A."/>
</authorList>
<dbReference type="PubMed" id="9182788"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19970627)70:4&lt;437::AID-AJMG19>3.0.CO;2-I"/>
</citation>
<scope>VARIANTS GD LEU-414 AND THR-441</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1997" name="Am. J. Med. Genet." volume="71" first="172" last="178">
<title>Identification of two novel and four uncommon missense mutations among Chinese Gaucher disease patients.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Shi H."/>
</authorList>
<dbReference type="PubMed" id="9217217"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19970808)71:2&lt;172::AID-AJMG10>3.0.CO;2-B"/>
</citation>
<scope>VARIANTS GD VAL-76; GLU-85; TRP-87; TRP-159; SER-227; ILE-252 AND PRO-483</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1997" name="Arch. Dis. Child." volume="77" first="17" last="22">
<title>Mutation analysis in 46 British and Irish patients with Gaucher's disease.</title>
<authorList>
<person name="Hatton C.E."/>
<person name="Cooper A."/>
<person name="Whitehouse C."/>
<person name="Wraith J.E."/>
</authorList>
<dbReference type="PubMed" id="9279145"/>
<dbReference type="DOI" id="10.1136/adc.77.1.17"/>
</citation>
<scope>VARIANT GD LYS-501</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1997" name="J. Clin. Invest." volume="99" first="2530" last="2537">
<title>Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.</title>
<authorList>
<person name="Grace M.E."/>
<person name="Desnick R.J."/>
<person name="Pastores G.M."/>
</authorList>
<dbReference type="PubMed" id="9153297"/>
<dbReference type="DOI" id="10.1172/JCI119437"/>
</citation>
<scope>VARIANTS GD TRP-87; GLU-234; ARG-241; ILE-252; ASN-310; LEU-391 AND SER-409</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1997" name="J. Inherit. Metab. Dis." volume="20" first="67" last="73">
<title>Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations.</title>
<authorList>
<person name="Ida H."/>
<person name="Rennert O.M."/>
<person name="Kawame H."/>
<person name="Maekawa K."/>
<person name="Eto Y."/>
</authorList>
<dbReference type="PubMed" id="9061570"/>
<dbReference type="DOI" id="10.1023/A:1005313724361"/>
</citation>
<scope>VARIANTS GD VAL-228; ILE-252; GLY-405; HIS-448; GLN-452; PRO-483 AND CYS-535</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1997" name="J. Med. Genet." volume="34" first="175" last="175">
<title>D409H/D409H genotype in Gaucher-like disease.</title>
<authorList>
<person name="Uyama E."/>
<person name="Uchino M."/>
<person name="Ida H."/>
<person name="Eto Y."/>
<person name="Owada M."/>
</authorList>
<dbReference type="PubMed" id="9040001"/>
<dbReference type="DOI" id="10.1136/jmg.34.2.175"/>
</citation>
<scope>VARIANT PSEUDO-GAUCHER HIS-448</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Acta Haematol." volume="99" first="80" last="82">
<title>Six new Gaucher disease mutations.</title>
<authorList>
<person name="Demina A."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="9554454"/>
<dbReference type="DOI" id="10.1159/000040815"/>
</citation>
<scope>VARIANTS GD LEU-146; LEU-198; THR-380; ASN-405 AND ARG-432</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="63" first="415" last="427">
<title>Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.</title>
<authorList>
<person name="Germain D.P."/>
<person name="Puech J.-P."/>
<person name="Caillaud C."/>
<person name="Kahn A."/>
<person name="Poenaru L."/>
</authorList>
<dbReference type="PubMed" id="9683600"/>
<dbReference type="DOI" id="10.1086/301969"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="78" first="92" last="93">
<title>Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Ben-Yoseph Y."/>
</authorList>
<dbReference type="PubMed" id="9637431"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980616)78:1&lt;92::AID-AJMG19>3.0.CO;2-J"/>
</citation>
<scope>VARIANT GD2 TYR-513</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="Blood Cells Mol. Dis." volume="24" first="2" last="8">
<title>Hematologically important mutations: Gaucher disease.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="9516376"/>
<dbReference type="DOI" id="10.1006/bcmd.1998.0165"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1998" name="Blood Cells Mol. Dis." volume="24" first="420" last="427">
<title>A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.</title>
<authorList>
<person name="Sinclair G."/>
<person name="Choy F.Y.M."/>
<person name="Humphries L."/>
</authorList>
<dbReference type="PubMed" id="9851895"/>
<dbReference type="DOI" id="10.1006/bcmd.1998.0210"/>
</citation>
<scope>VARIANTS GD2 LYS-80; CYS-170 AND PRO-483</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1998" name="Clin. Genet." volume="53" first="281" last="285">
<title>A novel mutation of the beta-glucocerebrosidase gene associated with neurologic manifestations in three sibs.</title>
<authorList>
<person name="Parenti G."/>
<person name="Filocamo M."/>
<person name="Titomanlio L."/>
<person name="Rizzolo G."/>
<person name="Silvestro E."/>
<person name="Perretti A."/>
<person name="Gatti R."/>
<person name="Andria G."/>
</authorList>
<dbReference type="PubMed" id="9650766"/>
</citation>
<scope>VARIANT GD GLY-392</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="295" last="305">
<title>Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.</title>
<authorList>
<person name="Cormand B."/>
<person name="Grinberg D."/>
<person name="Gort L."/>
<person name="Chabas A."/>
<person name="Vilageliu L."/>
</authorList>
<dbReference type="PubMed" id="9554746"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:4&lt;295::AID-HUMU7>3.0.CO;2-6"/>
</citation>
<scope>VARIANTS GD GLU-152; PRO-173; GLU-428; LEU-430; ILE-431 AND HIS-451</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="411" last="412">
<title>A novel mutation (V191G) in a German-British type 1 Gaucher disease patient.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Ben-Yoseph Y."/>
</authorList>
<dbReference type="PubMed" id="10206680"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:5&lt;411::AID-HUMU13>3.0.CO;2-X"/>
</citation>
<scope>VARIANTS GD1 GLY-230 AND SER-409</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="84" first="334" last="339">
<title>Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.</title>
<authorList>
<person name="Wasserstein M.P."/>
<person name="Martignetti J.A."/>
<person name="Zeitlin R."/>
<person name="Lumerman H."/>
<person name="Solomon M."/>
<person name="Grace M.E."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="10340647"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19990604)84:4&lt;334::AID-AJMG5>3.3.CO;2-G"/>
</citation>
<scope>VARIANTS GD1 SER-409 AND LEU-440</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="84" first="484" last="486">
<title>Glucocerebrosidase mutations among Chinese neuronopathic and non-neuronopathic Gaucher disease patients.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wong K."/>
<person name="Shi H.P."/>
</authorList>
<dbReference type="PubMed" id="10360404"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19990611)84:5&lt;484::AID-AJMG14>3.0.CO;2-W"/>
</citation>
<scope>VARIANTS GD ARG-241; CYS-244; ILE-252; HIS-448 AND PRO-483</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1999" name="Blood Cells Mol. Dis." volume="25" first="287" last="298">
<title>Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles.</title>
<authorList>
<person name="Hodanov K."/>
<person name="Hrebicek M."/>
<person name="Cervenkov M."/>
<person name="Mrzov L."/>
<person name="Veprekov L."/>
<person name="Zemen J."/>
</authorList>
<dbReference type="PubMed" id="10744424"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1999" name="Eur. J. Hum. Genet." volume="7" first="505" last="509">
<title>Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?</title>
<authorList>
<person name="Stone D.L."/>
<person name="van Diggelen O.P."/>
<person name="de Klerk J.B.C."/>
<person name="Gaillard J.L.J."/>
<person name="Niermeijer M.F."/>
<person name="Willemsen R."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10352942"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200315"/>
</citation>
<scope>VARIANTS PERINATAL LETHAL GD ARG-350 AND PHE-437</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="88" last="88">
<title>Detection of three rare (G377S, T134P and 1451delAC), and two novel mutations (G195W and Rec[1263del55;1342G>C]] in Spanish Gaucher disease patients.</title>
<authorList>
<person name="Sarria A.J."/>
<person name="Giraldo P."/>
<person name="Perez-Calvo J.I."/>
<person name="Pocovi M."/>
</authorList>
<dbReference type="PubMed" id="10447266"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)14:1&lt;88::AID-HUMU16>3.0.CO;2-E"/>
</citation>
<scope>VARIANTS GD PRO-173; TRP-234; SER-409; SER-416; HIS-448 AND PRO-483</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="1777" last="1786">
<title>Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.</title>
<authorList>
<person name="Koprivica V."/>
<person name="Stone D.L."/>
<person name="Park J.K."/>
<person name="Callahan M."/>
<person name="Frisch A."/>
<person name="Cohen I.J."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10796875"/>
<dbReference type="DOI" id="10.1086/302925"/>
</citation>
<scope>VARIANTS GD TRP-87; ASN-118; THR-129; ASP-156; GLN-159; TRP-159; LEU-170; ILE-173; CYS-209; PRO-209; SER-227; THR-229; PRO-235; ARG-241; ILE-252; GLN-296; CYS-324; THR-380; MET-408; SER-409; SER-416; LEU-433; TYR-438; HIS-448; PRO-483 AND CYS-502</scope>
<scope>VARIANT LYS-365</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="109" first="328" last="331">
<title>Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S).</title>
<authorList>
<person name="Bodamer O.A.F."/>
<person name="Church H.J."/>
<person name="Cooper A."/>
<person name="Wraith J.E."/>
<person name="Scott C.R."/>
<person name="Scaglia F."/>
</authorList>
<dbReference type="PubMed" id="11992489"/>
<dbReference type="DOI" id="10.1002/ajmg.10385"/>
</citation>
<scope>VARIANTS GD SER-55 AND HIS-448</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="19" first="458" last="459">
<title>The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.</title>
<authorList>
<person name="Orvisky E."/>
<person name="Park J.K."/>
<person name="Parker A."/>
<person name="Walker J.M."/>
<person name="Martin B.M."/>
<person name="Stubblefield B.K."/>
<person name="Uyama E."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="11933202"/>
<dbReference type="DOI" id="10.1002/humu.9024"/>
</citation>
<scope>VARIANTS GD GLU-175; PRO-201; GLU-237; LEU-290 AND PHE-441</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="234" last="235">
<title>Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients.</title>
<authorList>
<person name="Filocamo M."/>
<person name="Mazzotti R."/>
<person name="Stroppiano M."/>
<person name="Seri M."/>
<person name="Giona F."/>
<person name="Parenti G."/>
<person name="Regis S."/>
<person name="Corsolini F."/>
<person name="Zoboli S."/>
<person name="Gatti R."/>
</authorList>
<dbReference type="PubMed" id="12204005"/>
<dbReference type="DOI" id="10.1002/humu.9058"/>
</citation>
<scope>VARIANTS GD THR-198; ARG-241; ARG-270; ILE-400 AND ARG-490</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2003" name="Neurology" volume="61" first="99" last="101">
<title>Gaucher's disease with Parkinson's disease: clinical and pathological aspects.</title>
<authorList>
<person name="Bembi B."/>
<person name="Zambito Marsala S."/>
<person name="Sidransky E."/>
<person name="Ciana G."/>
<person name="Carrozzi M."/>
<person name="Zorzon M."/>
<person name="Martini C."/>
<person name="Gioulis M."/>
<person name="Pittis M.G."/>
<person name="Capus L."/>
</authorList>
<dbReference type="PubMed" id="12847165"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000072482.70963.D7"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN PARKINSON DISEASE</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2004" name="Eur. J. Hum. Genet." volume="12" first="975" last="978">
<title>Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.</title>
<authorList>
<person name="Church H.J."/>
<person name="Cooper A."/>
<person name="Stewart F."/>
<person name="Thornton C.M."/>
<person name="Wraith J.E."/>
</authorList>
<dbReference type="PubMed" id="15292921"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201251"/>
</citation>
<scope>VARIANT GD SER-55</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2005" name="Biochem. J." volume="390" first="95" last="103">
<title>The N370S (Asn370->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.</title>
<authorList>
<person name="Salvioli R."/>
<person name="Tatti M."/>
<person name="Scarpa S."/>
<person name="Moavero S.M."/>
<person name="Ciaffoni F."/>
<person name="Felicetti F."/>
<person name="Kaneski C.R."/>
<person name="Brady R.O."/>
<person name="Vaccaro A.M."/>
</authorList>
<dbReference type="PubMed" id="15826241"/>
<dbReference type="DOI" id="10.1042/BJ20050325"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GD SER-409</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="100" last="100">
<title>Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1.</title>
<authorList>
<person name="Miocic S."/>
<person name="Filocamo M."/>
<person name="Dominissini S."/>
<person name="Montalvo A.L."/>
<person name="Vlahovicek K."/>
<person name="Deganuto M."/>
<person name="Mazzotti R."/>
<person name="Cariati R."/>
<person name="Bembi B."/>
<person name="Pittis M.G."/>
</authorList>
<dbReference type="PubMed" id="15605411"/>
<dbReference type="DOI" id="10.1002/humu.9301"/>
</citation>
<scope>VARIANTS GD1 ASN-63; SER-158; TRP-159; CYS-170; LEU-221; GLU-230; ARG-241; GLN-294; CYS-324; SER-409; ASN-438; LEU-440; HIS-448; CYS-457; ASP-460; PRO-483 AND ARG-490</scope>
<scope>CHARACTERIZATION OF VARIANTS GD1 ASN-63; SER-158; LEU-221; GLU-230 AND ASP-460</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2005" name="Neurology" volume="65" first="1460" last="1461">
<title>Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.</title>
<authorList>
<person name="Aharon-Peretz J."/>
<person name="Badarny S."/>
<person name="Rosenbaum H."/>
<person name="Gershoni-Baruch R."/>
</authorList>
<dbReference type="PubMed" id="16148263"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000176987.47875.28"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN PARKINSON DISEASE</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Arch. Neurol." volume="64" first="1056" last="1058">
<title>Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients.</title>
<authorList>
<person name="Tan E.K."/>
<person name="Tong J."/>
<person name="Fook-Chong S."/>
<person name="Yih Y."/>
<person name="Wong M.C."/>
<person name="Pavanni R."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="17620502"/>
<dbReference type="DOI" id="10.1001/archneur.64.7.1056"/>
</citation>
<scope>INVOLVEMENT OF VARIANT GD PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2008" name="Arch. Neurol." volume="65" first="379" last="382">
<title>Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.</title>
<authorList>
<person name="Mata I.F."/>
<person name="Samii A."/>
<person name="Schneer S.H."/>
<person name="Roberts J.W."/>
<person name="Griffith A."/>
<person name="Leis B.C."/>
<person name="Schellenberg G.D."/>
<person name="Sidransky E."/>
<person name="Bird T.D."/>
<person name="Leverenz J.B."/>
<person name="Tsuang D."/>
<person name="Zabetian C.P."/>
</authorList>
<dbReference type="PubMed" id="18332251"/>
<dbReference type="DOI" id="10.1001/archneurol.2007.68"/>
</citation>
<scope>INVOLVEMENT OF VARIANTS GD SER-409 AND PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="361" first="1651" last="1661">
<title>Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.</title>
<authorList>
<person name="Sidransky E."/>
<person name="Nalls M.A."/>
<person name="Aasly J.O."/>
<person name="Aharon-Peretz J."/>
<person name="Annesi G."/>
<person name="Barbosa E.R."/>
<person name="Bar-Shira A."/>
<person name="Berg D."/>
<person name="Bras J."/>
<person name="Brice A."/>
<person name="Chen C.M."/>
<person name="Clark L.N."/>
<person name="Condroyer C."/>
<person name="De Marco E.V."/>
<person name="Durr A."/>
<person name="Eblan M.J."/>
<person name="Fahn S."/>
<person name="Farrer M.J."/>
<person name="Fung H.C."/>
<person name="Gan-Or Z."/>
<person name="Gasser T."/>
<person name="Gershoni-Baruch R."/>
<person name="Giladi N."/>
<person name="Griffith A."/>
<person name="Gurevich T."/>
<person name="Januario C."/>
<person name="Kropp P."/>
<person name="Lang A.E."/>
<person name="Lee-Chen G.J."/>
<person name="Lesage S."/>
<person name="Marder K."/>
<person name="Mata I.F."/>
<person name="Mirelman A."/>
<person name="Mitsui J."/>
<person name="Mizuta I."/>
<person name="Nicoletti G."/>
<person name="Oliveira C."/>
<person name="Ottman R."/>
<person name="Orr-Urtreger A."/>
<person name="Pereira L.V."/>
<person name="Quattrone A."/>
<person name="Rogaeva E."/>
<person name="Rolfs A."/>
<person name="Rosenbaum H."/>
<person name="Rozenberg R."/>
<person name="Samii A."/>
<person name="Samaddar T."/>
<person name="Schulte C."/>
<person name="Sharma M."/>
<person name="Singleton A."/>
<person name="Spitz M."/>
<person name="Tan E.K."/>
<person name="Tayebi N."/>
<person name="Toda T."/>
<person name="Troiano A.R."/>
<person name="Tsuji S."/>
<person name="Wittstock M."/>
<person name="Wolfsberg T.G."/>
<person name="Wu Y.R."/>
<person name="Zabetian C.P."/>
<person name="Zhao Y."/>
<person name="Ziegler S.G."/>
</authorList>
<dbReference type="PubMed" id="19846850"/>
<dbReference type="DOI" id="10.1056/NEJMoa0901281"/>
</citation>
<scope>INVOLVEMENT OF VARIANTS GD SER-409 AND PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<comment type="catalytic activity">
<text>D-glucosyl-N-acylsphingosine + H(2)O = D-glucose + N-acylsphingosine.</text>
</comment>
<comment type="enzyme regulation">
<text>Requires saposin-C and anionic phospholipids for activity.</text>
</comment>
<comment type="subunit">
<text evidence="14 25 32">Interacts with saposin-C. Interacts with SCARB2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564609"/>
<interactant intactId="EBI-1564519">
<id>O35114</id>
<label>Scarb2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>1</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="30 31 32">Lysosome membrane</location>
<topology evidence="30 31 32">Peripheral membrane protein</topology>
<orientation evidence="30 31 32">Lumenal side</orientation>
</subcellularLocation>
<text>Interaction with saposin-C promotes membrane association. Targeting to lysosomes occurs through an alternative MPR-independent mechanism via SCARB2.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P04062-1</id>
<name>Long</name>
<sequence type="displayed"/>
<text>Has a 39 residue signal sequence. The upstream initiation site produces two to three times as much protein as does the downstream initiation codon.</text>
</isoform>
<isoform>
<id>P04062-2</id>
<name>Short</name>
<sequence type="described" ref="VSP_018800"/>
<text>Has a 19 residue signal sequence.</text>
</isoform>
<isoform>
<id>P04062-3</id>
<name>3</name>
<sequence type="described" ref="VSP_025216 VSP_025217 VSP_025218"/>
<text>Produced by alternative splicing.</text>
</isoform>
<isoform>
<id>P04062-4</id>
<name>4</name>
<sequence type="described" ref="VSP_054655"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P04062-5</id>
<name>5</name>
<sequence type="described" ref="VSP_054656"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="disease" evidence="10 11 12 13 15 16 17 18 23 36 37 40 41 43 44 45 46 47 49 50 51 53 55 56 57 58 59 60 61 62 64 65">
<disease id="DI-03092">
<name>Gaucher disease</name>
<acronym>GD</acronym>
<description>A lysosomal storage disease due to deficient activity of beta-glucocerebrosidase and characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Different clinical forms are recognized depending on the presence (neuronopathic forms) or absence of central nervous system involvement, severity and age of onset.</description>
<dbReference type="MIM" id="230800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="8 9 24 52 68">
<disease id="DI-01647">
<name>Gaucher disease 1</name>
<acronym>GD1</acronym>
<description>A form of Gaucher disease characterized by hepatosplenomegaly with consequent anemia and thrombopenia, and bone involvement. The central nervous system is not involved.</description>
<dbReference type="MIM" id="230800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="63 66">
<disease id="DI-01648">
<name>Gaucher disease 2</name>
<acronym>GD2</acronym>
<description>The most severe form of Gaucher disease. It manifests soon after birth, with death generally occurring before patients reach two years of age.</description>
<dbReference type="MIM" id="230900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="48">
<disease id="DI-01649">
<name>Gaucher disease 3</name>
<acronym>GD3</acronym>
<description>A subacute form of neuronopathic Gaucher disease. It has later onset and slower progression compared to the acute form of neuronopathic Gaucher disease 2.</description>
<dbReference type="MIM" id="231000"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01650">
<name>Gaucher disease 3C</name>
<acronym>GD3C</acronym>
<description>A variant of subacute neuronopathic Gaucher disease 3 associated with cardiovascular calcifications.</description>
<dbReference type="MIM" id="231005"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02151">
<name>Gaucher disease perinatal lethal</name>
<acronym>GDPL</acronym>
<description>Distinct form of Gaucher disease type 2, characterized by fetal onset. Hydrops fetalis, in utero fetal death and neonatal distress are prominent features. When hydrops is absent, neurologic involvement begins in the first week and leads to death within 3 months. Hepatosplenomegaly is a major sign, and is associated with ichthyosis, arthrogryposis, and facial dysmorphism.</description>
<dbReference type="MIM" id="608013"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Perinatal lethal Gaucher disease is associated with non-immune hydrops fetalis, a generalized edema of the fetus with fluid accumulation in the body cavities due to non-immune causes. Non-immune hydrops fetalis is not a diagnosis in itself but a symptom, a feature of many genetic disorders, and the end-stage of a wide variety of disorders.</text>
</comment>
<comment type="disease" evidence="21 27 35">
<disease id="DI-02134">
<name>Parkinson disease</name>
<acronym>PARK</acronym>
<description>A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.</description>
<dbReference type="MIM" id="168600"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="pharmaceutical">
<text>Available under the names Ceredase and Cerezyme (Genzyme). Used to treat Gaucher's disease.</text>
</comment>
<comment type="similarity">
<text evidence="73">Belongs to the glycosyl hydrolase 30 family.</text>
</comment>
<comment type="online information" name="Ceredase">
<link uri="http://www.rxlist.com/ceredase-drug.htm"/>
<text>Clinical information on Ceredase</text>
</comment>
<comment type="online information" name="Cerezyme">
<link uri="http://www.rxlist.com/cerezyme-drug.htm"/>
<text>Clinical information on Cerezyme</text>
</comment>
<dbReference type="EC" id="3.2.1.45"/>
<dbReference type="EMBL" id="M16328">
<property type="protein sequence ID" value="AAA35873.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02920">
<property type="protein sequence ID" value="AAA35877.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J03059">
<property type="protein sequence ID" value="AAC63056.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D13286">
<property type="protein sequence ID" value="BAA02545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13287">
<property type="protein sequence ID" value="BAA02546.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF023268">
<property type="protein sequence ID" value="AAC51820.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291911">
<property type="protein sequence ID" value="BAF84600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298900">
<property type="protein sequence ID" value="BAH12898.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300829">
<property type="protein sequence ID" value="BAH13357.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713999">
<property type="protein sequence ID" value="CAI95090.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003356">
<property type="protein sequence ID" value="AAH03356.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M19285">
<property type="protein sequence ID" value="AAA35880.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M18916">
<property type="protein sequence ID" value="AAA35878.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M18917">
<property type="protein sequence ID" value="AAA35879.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20248">
<property type="protein sequence ID" value="AAA35874.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20282">
<property type="protein sequence ID" value="AAA35876.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1102.1">
<molecule id="P04062-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53373.1">
<molecule id="P04062-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53374.1">
<molecule id="P04062-5"/>
</dbReference>
<dbReference type="PIR" id="A94068">
<property type="entry name" value="EUHUGC"/>
</dbReference>
<dbReference type="PIR" id="I52980">
<property type="entry name" value="I52980"/>
</dbReference>
<dbReference type="PIR" id="I67792">
<property type="entry name" value="I67792"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000148.2">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_000157.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005741.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_001005741.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005742.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_001005742.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165282.1">
<molecule id="P04062-4"/>
<property type="nucleotide sequence ID" value="NM_001171811.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165283.1">
<molecule id="P04062-5"/>
<property type="nucleotide sequence ID" value="NM_001171812.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711333.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="XM_006711270.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011507709.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="XM_011509407.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.282997"/>
<dbReference type="PDB" id="1OGS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="1Y7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2F61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2J25">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NSX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NT1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2VT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2WCG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2WKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2XWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2XWE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.84"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3KE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3KEH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3RIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3RIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDBsum" id="1OGS"/>
<dbReference type="PDBsum" id="1Y7V"/>
<dbReference type="PDBsum" id="2F61"/>
<dbReference type="PDBsum" id="2J25"/>
<dbReference type="PDBsum" id="2NSX"/>
<dbReference type="PDBsum" id="2NT0"/>
<dbReference type="PDBsum" id="2NT1"/>
<dbReference type="PDBsum" id="2V3D"/>
<dbReference type="PDBsum" id="2V3E"/>
<dbReference type="PDBsum" id="2V3F"/>
<dbReference type="PDBsum" id="2VT0"/>
<dbReference type="PDBsum" id="2WCG"/>
<dbReference type="PDBsum" id="2WKL"/>
<dbReference type="PDBsum" id="2XWD"/>
<dbReference type="PDBsum" id="2XWE"/>
<dbReference type="PDBsum" id="3GXD"/>
<dbReference type="PDBsum" id="3GXF"/>
<dbReference type="PDBsum" id="3GXI"/>
<dbReference type="PDBsum" id="3GXM"/>
<dbReference type="PDBsum" id="3KE0"/>
<dbReference type="PDBsum" id="3KEH"/>
<dbReference type="PDBsum" id="3RIK"/>
<dbReference type="PDBsum" id="3RIL"/>
<dbReference type="ProteinModelPortal" id="P04062"/>
<dbReference type="SMR" id="P04062">
<property type="residue range" value="40-536"/>
</dbReference>
<dbReference type="BioGrid" id="108899">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="DIP" id="DIP-38645N"/>
<dbReference type="IntAct" id="P04062">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="MINT-3004354"/>
<dbReference type="STRING" id="9606.ENSP00000314508"/>
<dbReference type="BindingDB" id="P04062"/>
<dbReference type="ChEMBL" id="CHEMBL2179"/>
<dbReference type="DrugBank" id="DB06720">
<property type="generic name" value="Velaglucerase alfa"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001387"/>
<dbReference type="Allergome" id="8244">
<property type="allergen name" value="Hom s Glucocerebrosidase"/>
</dbReference>
<dbReference type="CAZy" id="GH30">
<property type="family name" value="Glycoside Hydrolase Family 30"/>
</dbReference>
<dbReference type="iPTMnet" id="P04062"/>
<dbReference type="PhosphoSite" id="P04062"/>
<dbReference type="BioMuta" id="GBA"/>
<dbReference type="DMDM" id="55584151"/>
<dbReference type="MaxQB" id="P04062"/>
<dbReference type="PaxDb" id="P04062"/>
<dbReference type="PRIDE" id="P04062"/>
<dbReference type="DNASU" id="2629"/>
<dbReference type="Ensembl" id="ENST00000327247">
<molecule id="P04062-1"/>
<property type="protein sequence ID" value="ENSP00000314508"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368373">
<molecule id="P04062-1"/>
<property type="protein sequence ID" value="ENSP00000357357"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427500">
<molecule id="P04062-5"/>
<property type="protein sequence ID" value="ENSP00000402577"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000428024">
<molecule id="P04062-4"/>
<property type="protein sequence ID" value="ENSP00000397986"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="GeneID" id="2629"/>
<dbReference type="KEGG" id="hsa:2629"/>
<dbReference type="UCSC" id="uc001fjh.3">
<molecule id="P04062-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2629"/>
<dbReference type="GeneCards" id="GBA"/>
<dbReference type="GeneReviews" id="GBA"/>
<dbReference type="H-InvDB" id="HIX0001123"/>
<dbReference type="HGNC" id="HGNC:4177">
<property type="gene designation" value="GBA"/>
</dbReference>
<dbReference type="HPA" id="CAB037171"/>
<dbReference type="HPA" id="CAB037289"/>
<dbReference type="HPA" id="HPA006667"/>
<dbReference type="MalaCards" id="GBA"/>
<dbReference type="MIM" id="168600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="230800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="230900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="231000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="231005">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606463">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608013">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04062"/>
<dbReference type="Orphanet" id="1648">
<property type="disease" value="Dementia with Lewy body"/>
</dbReference>
<dbReference type="Orphanet" id="85212">
<property type="disease" value="Fetal Gaucher disease"/>
</dbReference>
<dbReference type="Orphanet" id="2072">
<property type="disease" value="Gaucher disease - ophthalmoplegia - cardiovascular calcification"/>
</dbReference>
<dbReference type="Orphanet" id="77259">
<property type="disease" value="Gaucher disease type 1"/>
</dbReference>
<dbReference type="Orphanet" id="77260">
<property type="disease" value="Gaucher disease type 2"/>
</dbReference>
<dbReference type="Orphanet" id="77261">
<property type="disease" value="Gaucher disease type 3"/>
</dbReference>
<dbReference type="Orphanet" id="319705">
<property type="disease" value="Parkinson disease"/>
</dbReference>
<dbReference type="Orphanet" id="2828">
<property type="disease" value="Young adult-onset Parkinsonism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28591"/>
<dbReference type="eggNOG" id="KOG2566">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5520">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000009464"/>
<dbReference type="HOVERGEN" id="HBG002285"/>
<dbReference type="InParanoid" id="P04062"/>
<dbReference type="KO" id="K01201"/>
<dbReference type="OMA" id="QPDQKFQ"/>
<dbReference type="OrthoDB" id="EOG76DTRZ"/>
<dbReference type="PhylomeDB" id="P04062"/>
<dbReference type="TreeFam" id="TF314254"/>
<dbReference type="BRENDA" id="3.2.1.45">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660662">
<property type="pathway name" value="Glycosphingolipid metabolism"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04062"/>
<dbReference type="GeneWiki" id="Glucocerebrosidase"/>
<dbReference type="GenomeRNAi" id="2629"/>
<dbReference type="NextBio" id="10357"/>
<dbReference type="PRO" id="PR:P04062"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="P04062"/>
<dbReference type="CleanEx" id="HS_GBA"/>
<dbReference type="CleanEx" id="HS_GC"/>
<dbReference type="ExpressionAtlas" id="P04062">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04062">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004348">
<property type="term" value="F:glucosylceramidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005975">
<property type="term" value="P:carbohydrate metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046513">
<property type="term" value="P:ceramide biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006680">
<property type="term" value="P:glucosylceramide catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006687">
<property type="term" value="P:glycosphingolipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035307">
<property type="term" value="P:positive regulation of protein dephosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903052">
<property type="term" value="P:positive regulation of proteolysis involved in cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033561">
<property type="term" value="P:regulation of water loss via skin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051384">
<property type="term" value="P:response to glucocorticoid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009268">
<property type="term" value="P:response to pH"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033574">
<property type="term" value="P:response to testosterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097066">
<property type="term" value="P:response to thyroid hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043589">
<property type="term" value="P:skin morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044281">
<property type="term" value="P:small molecule metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006665">
<property type="term" value="P:sphingolipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046512">
<property type="term" value="P:sphingosine biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0023021">
<property type="term" value="P:termination of signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.1180">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.20.20.80">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013780">
<property type="entry name" value="Glyco_hydro_13_b"/>
</dbReference>
<dbReference type="InterPro" id="IPR001139">
<property type="entry name" value="Glyco_hydro_30"/>
</dbReference>
<dbReference type="InterPro" id="IPR013781">
<property type="entry name" value="Glyco_hydro_catalytic_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017853">
<property type="entry name" value="Glycoside_hydrolase_SF"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11069">
<property type="entry name" value="PTHR11069"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02055">
<property type="entry name" value="Glyco_hydro_30"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00843">
<property type="entry name" value="GLHYDRLASE30"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51445">
<property type="entry name" value="SSF51445"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0307">Gaucher disease</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0326">Glycosidase</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0977">Ichthyosis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0582">Pharmaceutical</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0746">Sphingolipid metabolism</keyword>
<feature type="signal peptide" description="In isoform Long" evidence="67">
<location>
<begin position="1"/>
<end position="39"/>
</location>
</feature>
<feature type="signal peptide" description="In isoform Short" evidence="67">
<location>
<begin position="21"/>
<end position="39"/>
</location>
</feature>
<feature type="chain" description="Glucosylceramidase" id="PRO_0000012177">
<location>
<begin position="40"/>
<end position="536"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="25">
<location>
<position position="274"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="25">
<location>
<position position="379"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="20 29">
<location>
<position position="58"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="19 29 34">
<location>
<position position="98"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="19 29">
<location>
<position position="185"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="19 34">
<location>
<position position="309"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="7">
<location>
<position position="501"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="43"/>
<end position="55"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025216" evidence="72">
<location>
<begin position="1"/>
<end position="161"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_054655" evidence="69">
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_018800" evidence="70 71">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_054656" evidence="69">
<location>
<begin position="103"/>
<end position="151"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025217" evidence="72">
<original>LA</original>
<variation>PS</variation>
<location>
<begin position="422"/>
<end position="423"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025218" evidence="72">
<location>
<begin position="425"/>
<end position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease." id="VAR_063066" evidence="35">
<original>K</original>
<variation>E</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003255" evidence="50">
<original>V</original>
<variation>L</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; neuronopathic and perinatal lethal forms; loss of activity." id="VAR_032394" evidence="17 23 28">
<original>C</original>
<variation>S</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity." id="VAR_032395" evidence="24">
<original>D</original>
<variation>N</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003256" evidence="58">
<original>F</original>
<variation>V</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In GD2; dbSNP:rs1141808." id="VAR_009033" evidence="66">
<original>E</original>
<variation>K</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003257">
<original>T</original>
<variation>I</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003258" evidence="50 58">
<original>G</original>
<variation>E</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 20% of normal activity." id="VAR_032197" evidence="28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs1141814." id="VAR_003259" evidence="15 56 58">
<original>R</original>
<variation>W</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3205619." id="VAR_032396">
<original>M</original>
<variation>T</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; 8% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_003260" evidence="15 28">
<original>K</original>
<variation>N</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032397" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_009034" evidence="61">
<original>S</original>
<variation>L</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003261" evidence="62">
<original>G</original>
<variation>E</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032398" evidence="15">
<original>N</original>
<variation>D</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity." id="VAR_032399" evidence="24">
<original>I</original>
<variation>S</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003262">
<original>I</original>
<variation>T</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 13% of normal activity." id="VAR_003263" evidence="15 28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003264" evidence="15 24 58">
<original>R</original>
<variation>W</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 16% of normal activity." id="VAR_032198" evidence="28">
<original>P</original>
<variation>L</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003265">
<original>P</original>
<variation>S</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032199" evidence="28">
<original>M</original>
<variation>V</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 9% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032200" evidence="28">
<original>D</original>
<variation>V</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1 and GD2; also found in a patient with Parkinson disease." id="VAR_009035" evidence="24 35 66">
<original>R</original>
<variation>C</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009036" evidence="15">
<original>R</original>
<variation>L</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032400" evidence="15">
<original>T</original>
<variation>I</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003266" evidence="12 62">
<original>T</original>
<variation>P</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032401" evidence="16">
<original>A</original>
<variation>E</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003267">
<original>D</original>
<variation>H</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003268">
<original>K</original>
<variation>Q</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009037" evidence="61">
<original>P</original>
<variation>L</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032402" evidence="18">
<original>P</original>
<variation>T</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity." id="VAR_032201" evidence="28">
<original>I</original>
<variation>N</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010059">
<original>I</original>
<variation>S</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032403" evidence="16">
<original>H</original>
<variation>P</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032404" evidence="15">
<original>R</original>
<variation>C</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003269" evidence="15">
<original>R</original>
<variation>P</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 12% of normal activity." id="VAR_032202" evidence="28">
<original>L</original>
<variation>F</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003270" evidence="49">
<original>A</original>
<variation>D</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003271" evidence="41">
<original>P</original>
<variation>S</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity." id="VAR_032405" evidence="24">
<original>P</original>
<variation>L</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003272" evidence="49">
<original>P</original>
<variation>T</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion." id="VAR_003273" evidence="46">
<original>W</original>
<variation>R</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 4% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032203" evidence="28">
<original>L</original>
<variation>F</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion; dbSNP:rs381418." id="VAR_003275">
<original>N</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs364897." id="VAR_003274" evidence="15 50 58">
<original>N</original>
<variation>S</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010060" evidence="55">
<original>G</original>
<variation>V</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_009038">
<original>A</original>
<variation>E</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032406" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity." id="VAR_032407" evidence="24">
<original>V</original>
<variation>E</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; gene conversion; dbSNP:rs381427." id="VAR_003276" evidence="8 46">
<original>V</original>
<variation>G</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; also found in a patient with Parkinson disease; 7% of normal activity." id="VAR_032204" evidence="28 35">
<original>G</original>
<variation>E</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003277" evidence="56">
<original>G</original>
<variation>E</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009039" evidence="12">
<original>G</original>
<variation>W</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; gene conversion; dbSNP:rs1064644." id="VAR_003278" evidence="15 46">
<original>S</original>
<variation>P</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032205" evidence="16 28">
<original>K</original>
<variation>E</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010061">
<original>G</original>
<variation>E</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type 2; gene conversion." id="VAR_003279" evidence="11 15 18 24 46 49 56">
<original>G</original>
<variation>R</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010062" evidence="11">
<original>Y</original>
<variation>C</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003280">
<original>Y</original>
<variation>H</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; gene conversion; dbSNP:rs381737." id="VAR_003281" evidence="11 15 46 55 56 58">
<original>F</original>
<variation>I</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003282" evidence="37">
<original>F</original>
<variation>Y</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032408" evidence="18">
<original>T</original>
<variation>R</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003283">
<original>S</original>
<variation>P</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; perinatal lethal form." id="VAR_032409" evidence="16">
<original>F</original>
<variation>L</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; also found in Gaucher disease type 2." id="VAR_009040" evidence="24">
<original>H</original>
<variation>Q</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; also found in a patient with Parkinson disease." id="VAR_003284" evidence="15 35 49">
<original>R</original>
<variation>Q</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 4% of normal activity." id="VAR_009041" evidence="28 39">
<original>F</original>
<variation>L</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity." id="VAR_032206" evidence="28">
<original>L</original>
<variation>I</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010063">
<original>G</original>
<variation>D</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003285">
<original>P</original>
<variation>R</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057942." id="VAR_032410" evidence="46">
<original>S</original>
<variation>G</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; less than 5% of normal activity." id="VAR_010064" evidence="56">
<original>S</original>
<variation>N</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1." id="VAR_003286" evidence="15 24 49">
<original>R</original>
<variation>C</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_009042">
<original>R</original>
<variation>H</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003287">
<original>P</original>
<variation>L</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003288">
<original>K</original>
<variation>I</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 16% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_009043" evidence="28">
<original>Y</original>
<variation>C</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003289">
<original>A</original>
<variation>V</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In perinatal lethal GD." id="VAR_009044" evidence="10">
<original>H</original>
<variation>R</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003290">
<original>W</original>
<variation>C</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003291" evidence="51">
<original>Y</original>
<variation>H</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003292">
<original>D</original>
<variation>H</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003293">
<original>A</original>
<variation>D</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 6% of normal activity." id="VAR_003294" evidence="28">
<original>T</original>
<variation>I</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003295">
<original>L</original>
<variation>P</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003296" evidence="46">
<original>G</original>
<variation>R</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; 42% of normal activity; dbSNP:rs2230288." id="VAR_003297" evidence="15 28">
<original>E</original>
<variation>K</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064648." id="VAR_032411" evidence="46">
<original>R</original>
<variation>H</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009045" evidence="15 61">
<original>A</original>
<variation>T</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; loss of activity." id="VAR_003298" evidence="28">
<original>C</original>
<variation>G</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 12% of normal activity." id="VAR_032207" evidence="28">
<original>E</original>
<variation>K</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010065" evidence="56">
<original>V</original>
<variation>L</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010066" evidence="64">
<original>R</original>
<variation>G</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity." id="VAR_032208" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003299" evidence="51">
<original>R</original>
<variation>Q</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs149487315." id="VAR_032412" evidence="18">
<original>M</original>
<variation>I</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 8% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032209" evidence="28">
<original>Y</original>
<variation>C</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003300">
<original>S</original>
<variation>T</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010067" evidence="55">
<original>S</original>
<variation>G</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009046" evidence="61">
<original>S</original>
<variation>N</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs2230289." id="VAR_003301" evidence="15 22">
<original>T</original>
<variation>M</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; common mutation; associated with susceptibility to Parkinson disease; alters interaction with saposin-C; mild; dbSNP:rs76763715." id="VAR_003302" evidence="8 9 12 15 24 26 28 33 35 38 40 44 53 56 68">
<original>N</original>
<variation>S</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 15% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032210" evidence="28">
<original>L</original>
<variation>V</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_010068" evidence="57">
<original>V</original>
<variation>L</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003303" evidence="12 15">
<original>G</original>
<variation>S</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003304" evidence="49">
<original>W</original>
<variation>G</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; also found in a patient with Parkinson disease." id="VAR_003305" evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 4% of normal activity." id="VAR_032211" evidence="28">
<original>D</original>
<variation>H</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003306" evidence="49">
<original>D</original>
<variation>N</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 22% of normal activity." id="VAR_032212" evidence="28">
<original>N</original>
<variation>K</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010069" evidence="53">
<original>P</original>
<variation>L</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003307" evidence="62">
<original>G</original>
<variation>E</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 17% of normal activity." id="VAR_032213" evidence="28">
<original>G</original>
<variation>R</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003308" evidence="62">
<original>P</original>
<variation>L</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003309" evidence="62">
<original>N</original>
<variation>I</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009047" evidence="61">
<original>W</original>
<variation>R</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; 12% of normal activity." id="VAR_003310" evidence="15 28 53">
<original>V</original>
<variation>L</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; mild." id="VAR_003311" evidence="52">
<original>N</original>
<variation>T</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 6% of normal activity; alters protein stability and increases susceptibility to proteolytic degradation." id="VAR_032214" evidence="28">
<original>F</original>
<variation>S</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In perinatal lethal GD." id="VAR_009048" evidence="10">
<original>V</original>
<variation>F</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In GD3." id="VAR_010070" evidence="48">
<original>V</original>
<variation>L</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type 2; 14% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_003312" evidence="24 28 45">
<original>D</original>
<variation>N</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032413" evidence="15">
<original>D</original>
<variation>Y</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1." id="VAR_010071" evidence="9 24">
<original>P</original>
<variation>L</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 3." id="VAR_032414" evidence="16">
<original>I</original>
<variation>F</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_010072" evidence="57">
<original>I</original>
<variation>T</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type neuronopathic; at homozygosity it causes GD3C; also found in a patient with Parkinson disease; gene conversion; very low activity; alters protein stability; dbSNP:rs1064651." id="VAR_003313" evidence="11 12 15 17 24 28 35 40 54 55">
<original>D</original>
<variation>H</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; very low activity; alters protein stability." id="VAR_003314">
<original>D</original>
<variation>V</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010073">
<original>F</original>
<variation>I</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003315" evidence="62">
<original>Y</original>
<variation>H</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010074" evidence="55">
<original>K</original>
<variation>Q</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003316">
<original>P</original>
<variation>R</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032215" evidence="28">
<original>M</original>
<variation>V</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003317">
<original>F</original>
<variation>V</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003318" evidence="24 44">
<original>Y</original>
<variation>C</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; associated with R-490; loss of activity." id="VAR_032415" evidence="24">
<original>G</original>
<variation>D</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003319">
<original>K</original>
<variation>E</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease; dbSNP:rs75671029." id="VAR_063067" evidence="35">
<original>D</original>
<variation>N</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1 and GD2; common mutation; associated with susceptibility to Parkinson disease; gene conversion; very low activity; alters protein stability." id="VAR_003321" evidence="11 12 15 24 28 35 40 53 55 58 66">
<original>L</original>
<variation>P</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003320">
<original>L</original>
<variation>R</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003322">
<original>A</original>
<variation>P</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1; associated with D-460." id="VAR_032416" evidence="18 24">
<original>H</original>
<variation>R</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion; dbSNP:rs368060." id="VAR_003323" evidence="35">
<original>A</original>
<variation>P</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_063068" evidence="35">
<original>V</original>
<variation>L</variation>
<location>
<position position="497"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 10% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032216" evidence="28">
<original>L</original>
<variation>P</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_009049" evidence="59">
<original>N</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 37% of normal activity; also found in patients with Parkinson disease." id="VAR_003324" evidence="15 35 36 40">
<original>R</original>
<variation>C</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032217" evidence="28">
<original>R</original>
<variation>P</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_003325">
<original>L</original>
<variation>P</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In GD2." id="VAR_009050" evidence="63">
<original>D</original>
<variation>Y</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003326">
<original>G</original>
<variation>S</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In GD3." id="VAR_010075" evidence="48">
<original>T</original>
<variation>I</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003327" evidence="55">
<original>R</original>
<variation>C</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild." id="VAR_003328" evidence="43">
<original>R</original>
<variation>H</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases activity 1000-fold." evidence="42">
<original>E</original>
<variation>G</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAH13357." ref="7" evidence="73">
<original>D</original>
<variation>G</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA02546." ref="5" evidence="73">
<original>N</original>
<variation>R</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 15; AA sequence." ref="15" evidence="73">
<original>S</original>
<variation>I</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35873." ref="1" evidence="73">
<original>R</original>
<variation>H</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="75"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="103"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="119"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="126"/>
<end position="133"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="137"/>
<end position="148"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="157"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="166"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="190"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="196"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="212"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="225"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="229"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="235"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="243"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="275"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="292"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="303"/>
<end position="308"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="315"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="324"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="329"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="338"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="346"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="359"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="373"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="386"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="396"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="414"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="426"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="440"/>
<end position="444"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="445"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="449"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="454"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="471"/>
<end position="479"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="482"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="495"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="507"/>
<end position="513"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="517"/>
<end position="523"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="527"/>
<end position="533"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OGS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J25"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NT0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GXF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GXI"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KEH"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10206680"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10340647"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10352942"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10360404"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10447266"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10744424"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10781797"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10796875"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11933202"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11992489"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12204005"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12792654"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12847165"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292921"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15605411"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15817452"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15826241"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16148263"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16293621"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17139081"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17187079"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17897319"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18022370"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18332251"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19286695"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1972019"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1974409"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19846850"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3001061"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7627184"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7627192"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7908905"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7916532"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8076951"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8112750"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8294033"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8432537"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8780099"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8790604"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8829654"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8829663"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8889591"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8937765"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9040001"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9061570"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9153297"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9182788"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9217217"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9279145"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9516376"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554454"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554746"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9637431"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9650766"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9683600"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9851895"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source ref="12"/>
</evidence>
<evidence key="68" type="ECO:0000269">
<source ref="14"/>
</evidence>
<evidence key="69" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3001061"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3864160"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8294033"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000305"/>
<sequence length="536" mass="59716" checksum="FA1E15684344A0E6" modified="2004-11-09" version="3" precursor="true">
MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNAT
YCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGF
GGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDD
FQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQP
GDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIA
RDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAK
ATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDW
NLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQK
NDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2004-10-11" modified="2016-01-20" version="163">
<accession>O60260</accession>
<accession>A3FG77</accession>
<accession>A8K975</accession>
<accession>D3JZW7</accession>
<accession>D3K2X0</accession>
<accession>Q5TFV8</accession>
<accession>Q5VVX4</accession>
<accession>Q6Q2I6</accession>
<accession>Q8NI41</accession>
<accession>Q8NI43</accession>
<accession>Q8NI44</accession>
<accession>Q8WW07</accession>
<name>PRKN2_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase parkin</fullName>
<shortName>Parkin</shortName>
<ecNumber>6.3.2.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Parkinson juvenile disease protein 2</fullName>
<shortName>Parkinson disease protein 2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PARK2</name>
<name type="synonym">PRKN</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Nature" volume="392" first="605" last="608">
<title>Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.</title>
<authorList>
<person name="Kitada T."/>
<person name="Asakawa S."/>
<person name="Hattori N."/>
<person name="Matsumine H."/>
<person name="Yamamura Y."/>
<person name="Minoshima S."/>
<person name="Yokochi M."/>
<person name="Mizuno Y."/>
<person name="Shimizu N."/>
</authorList>
<dbReference type="PubMed" id="9560156"/>
<dbReference type="DOI" id="10.1038/33416"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INVOLVEMENT IN PARK2</scope>
<source>
<tissue>Fetal brain</tissue>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2009" name="Neurosci. Lett." volume="460" first="196" last="200">
<title>Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood.</title>
<authorList>
<person name="Kasap M."/>
<person name="Akpinar G."/>
<person name="Sazci A."/>
<person name="Idrisoglu H.A."/>
<person name="Vahaboglu H."/>
</authorList>
<dbReference type="PubMed" id="19501131"/>
<dbReference type="DOI" id="10.1016/j.neulet.2009.05.079"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS ARG-311 AND THR-371</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="3">
<citation type="submission" date="2001-05" db="EMBL/GenBank/DDBJ databases">
<title>Functional and molecular diversity of parkin.</title>
<authorList>
<person name="D'Agata V."/>
<person name="Scapagnini G."/>
<person name="Cavallaro S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2009-12" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens PARK2 transcript variants.</title>
<authorList>
<person name="Campello L."/>
<person name="Esteve-Rudd J."/>
<person name="Cuenca N."/>
<person name="Martin-Nieto J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 7 AND 8)</scope>
<source>
<tissue>Retina</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2004-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Zou H.Q."/>
<person name="Chan P."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 312-361</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Ann. Neurol." volume="45" first="668" last="672">
<title>Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients.</title>
<authorList>
<person name="Shimura H."/>
<person name="Hattori N."/>
<person name="Kubo S."/>
<person name="Yoshikawa M."/>
<person name="Kitada T."/>
<person name="Matsumine H."/>
<person name="Asakawa S."/>
<person name="Minoshima S."/>
<person name="Yamamura Y."/>
<person name="Shimizu N."/>
<person name="Mizuno Y."/>
</authorList>
<dbReference type="PubMed" id="10319893"/>
<dbReference type="DOI" id="10.1002/1531-8249(199905)45:5&lt;668::AID-ANA19>3.0.CO;2-Z"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="35661" last="35664">
<title>Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.</title>
<authorList>
<person name="Imai Y."/>
<person name="Soda M."/>
<person name="Takahashi R."/>
</authorList>
<dbReference type="PubMed" id="10973942"/>
<dbReference type="DOI" id="10.1074/jbc.C000447200"/>
</citation>
<scope>FUNCTION IN UBIQUITINATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="302" last="305">
<title>Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.</title>
<authorList>
<person name="Shimura H."/>
<person name="Hattori N."/>
<person name="Kubo S."/>
<person name="Mizuno Y."/>
<person name="Asakawa S."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Iwai K."/>
<person name="Chiba T."/>
<person name="Tanaka K."/>
<person name="Suzuki T."/>
</authorList>
<dbReference type="PubMed" id="10888878"/>
<dbReference type="DOI" id="10.1038/77060"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="13354" last="13359">
<title>Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Gao J."/>
<person name="Chung K.K.K."/>
<person name="Huang H."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="11078524"/>
<dbReference type="DOI" id="10.1073/pnas.240347797"/>
</citation>
<scope>INTERACTION WITH UBE2L6 AND SEPT5</scope>
<scope>UBIQUITINATION OF SEPT5</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Cell" volume="105" first="891" last="902">
<title>An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.</title>
<authorList>
<person name="Imai Y."/>
<person name="Soda M."/>
<person name="Inoue H."/>
<person name="Hattori N."/>
<person name="Mizuno Y."/>
<person name="Takahashi R."/>
</authorList>
<dbReference type="PubMed" id="11439185"/>
<dbReference type="DOI" id="10.1016/S0092-8674(01)00407-X"/>
</citation>
<scope>UBIQUITINATION OF GPR37</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="1144" last="1150">
<title>Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.</title>
<authorList>
<person name="Chung K.K.K."/>
<person name="Zhang Y."/>
<person name="Lim K.L."/>
<person name="Tanaka Y."/>
<person name="Huang H."/>
<person name="Gao J."/>
<person name="Ross C.A."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="11590439"/>
<dbReference type="DOI" id="10.1038/nm1001-1144"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 ARG-240; CYS-256; TRP-275 AND ASN-415</scope>
<scope>MUTAGENESIS OF CYS-337; CYS-421 AND CYS-431</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Science" volume="293" first="263" last="269">
<title>Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.</title>
<authorList>
<person name="Shimura H."/>
<person name="Schlossmacher M.G."/>
<person name="Hattori N."/>
<person name="Frosch M.P."/>
<person name="Trockenbacher A."/>
<person name="Schneider R."/>
<person name="Mizuno Y."/>
<person name="Kosik K.S."/>
<person name="Selkoe D.J."/>
</authorList>
<dbReference type="PubMed" id="11431533"/>
<dbReference type="DOI" id="10.1126/science.1060627"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Mol. Biol. Evol." volume="19" first="2039" last="2050">
<title>Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily.</title>
<authorList>
<person name="Marin I."/>
<person name="Ferrus A."/>
</authorList>
<dbReference type="PubMed" id="12446796"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.molbev.a004029"/>
</citation>
<scope>PRESENCE OF ATYPICAL RING FINGER DOMAINS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Mol. Cell" volume="10" first="55" last="67">
<title>CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.</title>
<authorList>
<person name="Imai Y."/>
<person name="Soda M."/>
<person name="Hatakeyama S."/>
<person name="Akagi T."/>
<person name="Hashikawa T."/>
<person name="Nakayama K."/>
<person name="Takahashi R."/>
</authorList>
<dbReference type="PubMed" id="12150907"/>
<dbReference type="DOI" id="10.1016/S1097-2765(02)00583-X"/>
</citation>
<scope>INTERACTION WITH STUB1 AND HSP70</scope>
<scope>UBIQUITINATION OF STUB1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2587" last="2597">
<title>The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.</title>
<authorList>
<person name="Huynh D.P."/>
<person name="Scoles D.R."/>
<person name="Nguyen D."/>
<person name="Pulst S.M."/>
</authorList>
<dbReference type="PubMed" id="12925569"/>
<dbReference type="DOI" id="10.1093/hmg/ddg269"/>
</citation>
<scope>INTERACTION WITH SYT11</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 GLY-289 AND ARG-418</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="51901" last="51910">
<title>A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death.</title>
<authorList>
<person name="Imai Y."/>
<person name="Soda M."/>
<person name="Murakami T."/>
<person name="Shoji M."/>
<person name="Abe K."/>
<person name="Takahashi R."/>
</authorList>
<dbReference type="PubMed" id="14532270"/>
<dbReference type="DOI" id="10.1074/jbc.M309655200"/>
</citation>
<scope>INTERACTION WITH PACRG</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Neuron" volume="37" first="735" last="749">
<title>Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.</title>
<authorList>
<person name="Staropoli J.F."/>
<person name="McDermott C."/>
<person name="Martinat C."/>
<person name="Schulman B."/>
<person name="Demireva E."/>
<person name="Abeliovich A."/>
</authorList>
<dbReference type="PubMed" id="12628165"/>
<dbReference type="DOI" id="10.1016/S0896-6273(03)00084-9"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBXW7 AND CUL1</scope>
<scope>UBIQUITINATION OF CYCLIN E</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="8370" last="8378">
<title>Alterations in the common fragile site gene Parkin in ovarian and other cancers.</title>
<authorList>
<person name="Denison S.R."/>
<person name="Wang F."/>
<person name="Becker N.A."/>
<person name="Schuele B."/>
<person name="Kock N."/>
<person name="Phillips L.A."/>
<person name="Klein C."/>
<person name="Smith D.I."/>
</authorList>
<dbReference type="PubMed" id="14614460"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207072"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="5956" last="5961">
<title>Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.</title>
<authorList>
<person name="Cesari R."/>
<person name="Martin E.S."/>
<person name="Calin G.A."/>
<person name="Pentimalli F."/>
<person name="Bichi R."/>
<person name="McAdams H."/>
<person name="Trapasso F."/>
<person name="Drusco A."/>
<person name="Shimizu M."/>
<person name="Masciullo V."/>
<person name="D'Andrilli G."/>
<person name="Scambia G."/>
<person name="Picchio M.C."/>
<person name="Alder H."/>
<person name="Godwin A.K."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="12719539"/>
<dbReference type="DOI" id="10.1073/pnas.0931262100"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="EMBO Rep." volume="5" first="681" last="685">
<title>How does parkin ligate ubiquitin to Parkinson's disease?</title>
<authorList>
<person name="Kahle P.J."/>
<person name="Haass C."/>
</authorList>
<dbReference type="PubMed" id="15229644"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400188"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Science" volume="304" first="1328" last="1331">
<title>S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.</title>
<authorList>
<person name="Chung K.K.K."/>
<person name="Thomas B."/>
<person name="Li X."/>
<person name="Pletnikova O."/>
<person name="Troncoso J.C."/>
<person name="Marsh L."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="15105460"/>
<dbReference type="DOI" id="10.1126/science.1093891"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>S-NITROSYLATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="3913" last="3919">
<title>Parkin interacts with the proteasome subunit alpha4.</title>
<authorList>
<person name="Dachsel J.C."/>
<person name="Lucking C.B."/>
<person name="Deeg S."/>
<person name="Schultz E."/>
<person name="Lalowski M."/>
<person name="Casademunt E."/>
<person name="Corti O."/>
<person name="Hampe C."/>
<person name="Patenge N."/>
<person name="Vaupel K."/>
<person name="Yamamoto A."/>
<person name="Dichgans M."/>
<person name="Brice A."/>
<person name="Wanker E.E."/>
<person name="Kahle P.J."/>
<person name="Gasser T."/>
</authorList>
<dbReference type="PubMed" id="15987638"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.06.003"/>
</citation>
<scope>INTERACTION WITH PSMA7</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Neurosci." volume="25" first="2002" last="2009">
<title>Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.</title>
<authorList>
<person name="Lim K.L."/>
<person name="Chew K.C."/>
<person name="Tan J.M."/>
<person name="Wang C."/>
<person name="Chung K.K."/>
<person name="Zhang Y."/>
<person name="Tanaka Y."/>
<person name="Smith W."/>
<person name="Engelender S."/>
<person name="Ross C.A."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="15728840"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.4474-04.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNCAIP</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Neurosci." volume="25" first="7968" last="7978">
<title>Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.</title>
<authorList>
<person name="Ko H.S."/>
<person name="von Coelln R."/>
<person name="Sriram S.R."/>
<person name="Kim S.W."/>
<person name="Chung K.K.K."/>
<person name="Pletnikova O."/>
<person name="Troncoso J."/>
<person name="Johnson B."/>
<person name="Saffary R."/>
<person name="Goh E.L."/>
<person name="Song H."/>
<person name="Park B.-J."/>
<person name="Kim M.J."/>
<person name="Kim S."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="16135753"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.2172-05.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AIMP2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="18676" last="18681">
<title>Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin and mutant LRRK2 induces neuronal degeneration.</title>
<authorList>
<person name="Smith W.W."/>
<person name="Pei Z."/>
<person name="Jiang H."/>
<person name="Moore D.J."/>
<person name="Liang Y."/>
<person name="West A.B."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="16352719"/>
<dbReference type="DOI" id="10.1073/pnas.0508052102"/>
</citation>
<scope>INTERACTION WITH LRRK2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3595" last="3603">
<title>Parkin ubiquitinates and promotes the degradation of RanBP2.</title>
<authorList>
<person name="Um J.W."/>
<person name="Min D.S."/>
<person name="Rhim H."/>
<person name="Kim J."/>
<person name="Paik S.R."/>
<person name="Chung K.C."/>
</authorList>
<dbReference type="PubMed" id="16332688"/>
<dbReference type="DOI" id="10.1074/jbc.M504994200"/>
</citation>
<scope>INTERACTION WITH RANBP2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="J. Neurosci. Res." volume="84" first="1543" last="1554">
<title>Functional modulation of parkin through physical interaction with SUMO-1.</title>
<authorList>
<person name="Um J.W."/>
<person name="Chung K.C."/>
</authorList>
<dbReference type="PubMed" id="16955485"/>
<dbReference type="DOI" id="10.1002/jnr.21041"/>
</citation>
<scope>INTERACTION WITH SUMO1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="178" first="1025" last="1038">
<title>Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6.</title>
<authorList>
<person name="Olzmann J.A."/>
<person name="Li L."/>
<person name="Chudaev M.V."/>
<person name="Chen J."/>
<person name="Perez F.A."/>
<person name="Palmiter R.D."/>
<person name="Chin L.S."/>
</authorList>
<dbReference type="PubMed" id="17846173"/>
<dbReference type="DOI" id="10.1083/jcb.200611128"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="183" first="795" last="803">
<title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.</title>
<authorList>
<person name="Narendra D."/>
<person name="Tanaka A."/>
<person name="Suen D.F."/>
<person name="Youle R.J."/>
</authorList>
<dbReference type="PubMed" id="19029340"/>
<dbReference type="DOI" id="10.1083/jcb.200809125"/>
</citation>
<scope>FUNCTION IN MITOCHONDRIAL AUTOPHAGY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Neurosci. Lett." volume="440" first="4" last="8">
<title>Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress.</title>
<authorList>
<person name="Yu F."/>
<person name="Zhou J."/>
</authorList>
<dbReference type="PubMed" id="18541373"/>
<dbReference type="DOI" id="10.1016/j.neulet.2008.05.052"/>
</citation>
<scope>INTERACTION WITH RNF41</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF CYS-421</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="J. Clin. Invest." volume="119" first="650" last="660">
<title>Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.</title>
<authorList>
<person name="Xiong H."/>
<person name="Wang D."/>
<person name="Chen L."/>
<person name="Choo Y.S."/>
<person name="Ma H."/>
<person name="Tang C."/>
<person name="Xia K."/>
<person name="Jiang W."/>
<person name="Ronai Z."/>
<person name="Zhuang X."/>
<person name="Zhang Z."/>
</authorList>
<dbReference type="PubMed" id="19229105"/>
<dbReference type="DOI" id="10.1172/JCI37617"/>
</citation>
<scope>FUNCTION</scope>
<scope>COMPONENT OF A COMPLEX COMPOSED OF PARK2; PARK7 AND PINK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>CHARACTERIZATION OF VARIANT PARK2 PRO-42</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="1370" last="1375">
<title>Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.</title>
<authorList>
<person name="da Costa C.A."/>
<person name="Sunyach C."/>
<person name="Giaime E."/>
<person name="West A."/>
<person name="Corti O."/>
<person name="Brice A."/>
<person name="Safe S."/>
<person name="Abou-Sleiman P.M."/>
<person name="Wood N.W."/>
<person name="Takahashi H."/>
<person name="Goldberg M.S."/>
<person name="Shen J."/>
<person name="Checler F."/>
</authorList>
<dbReference type="PubMed" id="19801972"/>
<dbReference type="DOI" id="10.1038/ncb1981"/>
</citation>
<scope>FUNCTION IN PROTECTION OF APOPTOSIS</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 ASN-161; CYS-256; TRP-275; ARG-418 AND ARG-441</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Autophagy" volume="6" first="871" last="878">
<title>The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations.</title>
<authorList>
<person name="Geisler S."/>
<person name="Holmstrom K.M."/>
<person name="Treis A."/>
<person name="Skujat D."/>
<person name="Weber S.S."/>
<person name="Fiesel F.C."/>
<person name="Kahle P.J."/>
<person name="Springer W."/>
</authorList>
<dbReference type="PubMed" id="20798600"/>
<dbReference type="DOI" id="10.4161/auto.6.7.13286"/>
</citation>
<scope>INTERACTION WITH PINK1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="38214" last="38223">
<title>Parkin mono-ubiquitinates Bcl-2 and regulates autophagy.</title>
<authorList>
<person name="Chen D."/>
<person name="Gao F."/>
<person name="Li B."/>
<person name="Wang H."/>
<person name="Xu Y."/>
<person name="Zhu C."/>
<person name="Wang G."/>
</authorList>
<dbReference type="PubMed" id="20889974"/>
<dbReference type="DOI" id="10.1074/jbc.M110.101469"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BCL2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ARG-240; PHE-431 AND LEU-437</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="378" last="383">
<title>PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.</title>
<authorList>
<person name="Vives-Bauza C."/>
<person name="Zhou C."/>
<person name="Huang Y."/>
<person name="Cui M."/>
<person name="de Vries R.L."/>
<person name="Kim J."/>
<person name="May J."/>
<person name="Tocilescu M.A."/>
<person name="Liu W."/>
<person name="Ko H.S."/>
<person name="Magrane J."/>
<person name="Moore D.J."/>
<person name="Dawson V.L."/>
<person name="Grailhe R."/>
<person name="Dawson T.M."/>
<person name="Li C."/>
<person name="Tieu K."/>
<person name="Przedborski S."/>
</authorList>
<dbReference type="PubMed" id="19966284"/>
<dbReference type="DOI" id="10.1073/pnas.0911187107"/>
</citation>
<scope>FUNCTION IN MITOCHONDRIAL AUTOPHAGY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PINK1</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK ASN-415 AND ASP-430</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Cell" volume="144" first="689" last="702">
<title>PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease.</title>
<authorList>
<person name="Shin J.H."/>
<person name="Ko H.S."/>
<person name="Kang H."/>
<person name="Lee Y."/>
<person name="Lee Y.I."/>
<person name="Pletinkova O."/>
<person name="Troconso J.C."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="21376232"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.02.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZNF746</scope>
<scope>CHARACTERIZATION OF VARIANTS PARK2 TRP-275; ASP-430 AND PHE-431</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Nature" volume="474" first="105" last="108">
<title>UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids.</title>
<authorList>
<person name="Wenzel D.M."/>
<person name="Lissounov A."/>
<person name="Brzovic P.S."/>
<person name="Klevit R.E."/>
</authorList>
<dbReference type="PubMed" id="21532592"/>
<dbReference type="DOI" id="10.1038/nature09966"/>
</citation>
<scope>FUNCTION</scope>
<scope>REACTION MECHANISM</scope>
<scope>INTERACTION WITH UBE2L3</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Hum. Mol. Genet." volume="21" first="991" last="1003">
<title>Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential.</title>
<authorList>
<person name="Kuroda Y."/>
<person name="Sako W."/>
<person name="Goto S."/>
<person name="Sawada T."/>
<person name="Uchida D."/>
<person name="Izumi Y."/>
<person name="Takahashi T."/>
<person name="Kagawa N."/>
<person name="Matsumoto M."/>
<person name="Matsumoto M."/>
<person name="Takahashi R."/>
<person name="Kaji R."/>
<person name="Mitsui T."/>
</authorList>
<dbReference type="PubMed" id="22082830"/>
<dbReference type="DOI" id="10.1093/hmg/ddr530"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHPF</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="22019" last="22032">
<title>Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.</title>
<authorList>
<person name="Iguchi M."/>
<person name="Kujuro Y."/>
<person name="Okatsu K."/>
<person name="Koyano F."/>
<person name="Kosako H."/>
<person name="Kimura M."/>
<person name="Suzuki N."/>
<person name="Uchiyama S."/>
<person name="Tanaka K."/>
<person name="Matsuda N."/>
</authorList>
<dbReference type="PubMed" id="23754282"/>
<dbReference type="DOI" id="10.1074/jbc.M113.467530"/>
</citation>
<scope>PHOSPHORYLATION AT SER-65</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="Nat. Neurosci." volume="16" first="1257" last="1265">
<title>The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.</title>
<authorList>
<person name="Burchell V.S."/>
<person name="Nelson D.E."/>
<person name="Sanchez-Martinez A."/>
<person name="Delgado-Camprubi M."/>
<person name="Ivatt R.M."/>
<person name="Pogson J.H."/>
<person name="Randle S.J."/>
<person name="Wray S."/>
<person name="Lewis P.A."/>
<person name="Houlden H."/>
<person name="Abramov A.Y."/>
<person name="Hardy J."/>
<person name="Wood N.W."/>
<person name="Whitworth A.J."/>
<person name="Laman H."/>
<person name="Plun-Favreau H."/>
</authorList>
<dbReference type="PubMed" id="23933751"/>
<dbReference type="DOI" id="10.1038/nn.3489"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH FBXO7</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="Nature" volume="504" first="291" last="295">
<title>High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy.</title>
<authorList>
<person name="Hasson S.A."/>
<person name="Kane L.A."/>
<person name="Yamano K."/>
<person name="Huang C.H."/>
<person name="Sliter D.A."/>
<person name="Buehler E."/>
<person name="Wang C."/>
<person name="Heman-Ackah S.M."/>
<person name="Hessa T."/>
<person name="Guha R."/>
<person name="Martin S.E."/>
<person name="Youle R.J."/>
</authorList>
<dbReference type="PubMed" id="24270810"/>
<dbReference type="DOI" id="10.1038/nature12748"/>
</citation>
<scope>INTERACTION WITH BAG4; BAG5; HSPA1L; HSPA1A AND HSPA8</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Science" volume="340" first="471" last="475">
<title>PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.</title>
<authorList>
<person name="Chen Y."/>
<person name="Dorn G.W. II"/>
</authorList>
<dbReference type="PubMed" id="23620051"/>
<dbReference type="DOI" id="10.1126/science.1231031"/>
</citation>
<scope>FUNCTION IN MITOPHAGY</scope>
<scope>INTERACTION WITH MFN2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="Biochem. J." volume="460" first="127" last="139">
<title>Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65.</title>
<authorList>
<person name="Kazlauskaite A."/>
<person name="Kondapalli C."/>
<person name="Gourlay R."/>
<person name="Campbell D.G."/>
<person name="Ritorto M.S."/>
<person name="Hofmann K."/>
<person name="Alessi D.R."/>
<person name="Knebel A."/>
<person name="Trost M."/>
<person name="Muqit M.M."/>
</authorList>
<dbReference type="PubMed" id="24660806"/>
<dbReference type="DOI" id="10.1042/BJ20140334"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-65</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF SER-65</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="J. Cell Biol." volume="205" first="143" last="153">
<title>PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.</title>
<authorList>
<person name="Kane L.A."/>
<person name="Lazarou M."/>
<person name="Fogel A.I."/>
<person name="Li Y."/>
<person name="Yamano K."/>
<person name="Sarraf S.A."/>
<person name="Banerjee S."/>
<person name="Youle R.J."/>
</authorList>
<dbReference type="PubMed" id="24751536"/>
<dbReference type="DOI" id="10.1083/jcb.201402104"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="Nature" volume="510" first="162" last="166">
<title>Ubiquitin is phosphorylated by PINK1 to activate parkin.</title>
<authorList>
<person name="Koyano F."/>
<person name="Okatsu K."/>
<person name="Kosako H."/>
<person name="Tamura Y."/>
<person name="Go E."/>
<person name="Kimura M."/>
<person name="Kimura Y."/>
<person name="Tsuchiya H."/>
<person name="Yoshihara H."/>
<person name="Hirokawa T."/>
<person name="Endo T."/>
<person name="Fon E.A."/>
<person name="Trempe J.F."/>
<person name="Saeki Y."/>
<person name="Tanaka K."/>
<person name="Matsuda N."/>
</authorList>
<dbReference type="PubMed" id="24784582"/>
<dbReference type="DOI" id="10.1038/nature13392"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-65</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF SER-65 AND TRP-403</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2014" name="Nature" volume="510" first="370" last="375">
<title>The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.</title>
<authorList>
<person name="Bingol B."/>
<person name="Tea J.S."/>
<person name="Phu L."/>
<person name="Reichelt M."/>
<person name="Bakalarski C.E."/>
<person name="Song Q."/>
<person name="Foreman O."/>
<person name="Kirkpatrick D.S."/>
<person name="Sheng M."/>
</authorList>
<dbReference type="PubMed" id="24896179"/>
<dbReference type="DOI" id="10.1038/nature13418"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="EMBO J." volume="34" first="307" last="325">
<title>Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis.</title>
<authorList>
<person name="Wauer T."/>
<person name="Swatek K.N."/>
<person name="Wagstaff J.L."/>
<person name="Gladkova C."/>
<person name="Pruneda J.N."/>
<person name="Michel M.A."/>
<person name="Gersch M."/>
<person name="Johnson C.M."/>
<person name="Freund S.M."/>
<person name="Komander D."/>
</authorList>
<dbReference type="PubMed" id="25527291"/>
<dbReference type="DOI" id="10.15252/embj.201489847"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Nat. Cell Biol." volume="17" first="160" last="169">
<title>USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria.</title>
<authorList>
<person name="Cunningham C.N."/>
<person name="Baughman J.M."/>
<person name="Phu L."/>
<person name="Tea J.S."/>
<person name="Yu C."/>
<person name="Coons M."/>
<person name="Kirkpatrick D.S."/>
<person name="Bingol B."/>
<person name="Corn J.E."/>
</authorList>
<dbReference type="PubMed" id="25621951"/>
<dbReference type="DOI" id="10.1038/ncb3097"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2003" name="EMBO Rep." volume="4" first="301" last="306">
<title>Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain.</title>
<authorList>
<person name="Sakata E."/>
<person name="Yamaguchi Y."/>
<person name="Kurimoto E."/>
<person name="Kikuchi J."/>
<person name="Yokoyama S."/>
<person name="Yamada S."/>
<person name="Kawahara H."/>
<person name="Yokosawa H."/>
<person name="Hattori N."/>
<person name="Mizuno Y."/>
<person name="Tanaka K."/>
<person name="Kato K."/>
</authorList>
<dbReference type="PubMed" id="12634850"/>
<dbReference type="DOI" id="10.1038/sj.embor.embor764"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-76</scope>
<scope>INTERACTION WITH PSMD4</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="3095" last="3100">
<title>Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.</title>
<authorList>
<person name="Beasley S.A."/>
<person name="Hristova V.A."/>
<person name="Shaw G.S."/>
</authorList>
<dbReference type="PubMed" id="17360614"/>
<dbReference type="DOI" id="10.1073/pnas.0610548104"/>
</citation>
<scope>STRUCTURE BY NMR OF 307-384 IN COMPLEX WITH ZINC IONS</scope>
<scope>CHARACTERIZATION OF VARIANT PARK2 PRO-351</scope>
<scope>MUTAGENESIS OF CYS-332 AND CYS-365</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2013" name="EMBO J." volume="32" first="2099" last="2112">
<title>Structure of the human Parkin ligase domain in an autoinhibited state.</title>
<authorList>
<person name="Wauer T."/>
<person name="Komander D."/>
</authorList>
<dbReference type="PubMed" id="23727886"/>
<dbReference type="DOI" id="10.1038/emboj.2013.125"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 137-465</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="1982" last="1982">
<title>Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases.</title>
<authorList>
<person name="Riley B.E."/>
<person name="Lougheed J.C."/>
<person name="Callaway K."/>
<person name="Velasquez M."/>
<person name="Brecht E."/>
<person name="Nguyen L."/>
<person name="Shaler T."/>
<person name="Walker D."/>
<person name="Yang Y."/>
<person name="Regnstrom K."/>
<person name="Diep L."/>
<person name="Zhang Z."/>
<person name="Chiou S."/>
<person name="Bova M."/>
<person name="Artis D.R."/>
<person name="Yao N."/>
<person name="Baker J."/>
<person name="Yednock T."/>
<person name="Johnston J.A."/>
</authorList>
<dbReference type="PubMed" id="23770887"/>
<dbReference type="DOI" id="10.1038/ncomms2982"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 137-465</scope>
<scope>ACTIVE SITE</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="R127" last="R133">
<title>Parkin genetics: one model for Parkinson's disease.</title>
<authorList>
<person name="Mata I.F."/>
<person name="Lockhart P.J."/>
<person name="Farrer M.J."/>
</authorList>
<dbReference type="PubMed" id="14976155"/>
<dbReference type="DOI" id="10.1093/hmg/ddh089"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="249" first="754" last="758">
<title>Point mutations (Thr240Arg and Gln311Stop) in the Parkin gene.</title>
<authorList>
<person name="Hattori N."/>
<person name="Matsumine H."/>
<person name="Asakawa S."/>
<person name="Kitada T."/>
<person name="Yoshino H."/>
<person name="Elibol B."/>
<person name="Brookes A.J."/>
<person name="Yamamura Y."/>
<person name="Kobayashi T."/>
<person name="Wang M."/>
<person name="Yoritaka A."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Mizuno Y."/>
</authorList>
<dbReference type="PubMed" id="9731209"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.9134"/>
</citation>
<scope>VARIANT PARK2 ARG-240</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="251" first="666" last="666">
<authorList>
<person name="Hattori N."/>
<person name="Matsumine H."/>
<person name="Asakawa S."/>
<person name="Kitada T."/>
<person name="Yoshino H."/>
<person name="Elibol B."/>
<person name="Brookes A.J."/>
<person name="Yamamura Y."/>
<person name="Kobayashi T."/>
<person name="Wang M."/>
<person name="Yoritaka A."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Mizuno Y."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="567" last="574">
<title>A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe.</title>
<authorList>
<person name="Abbas N."/>
<person name="Luecking C.B."/>
<person name="Ricard S."/>
<person name="Duerr A."/>
<person name="Bonifati V."/>
<person name="De Michele G."/>
<person name="Bouley S."/>
<person name="Vaughan J.R."/>
<person name="Gasser T."/>
<person name="Marconi R."/>
<person name="Broussolle E."/>
<person name="Brefel-Courbon C."/>
<person name="Harhangi B.S."/>
<person name="Oostra B.A."/>
<person name="Fabrizio E."/>
<person name="Bohme G.A."/>
<person name="Pradier L."/>
<person name="Wood N.W."/>
<person name="Filla A."/>
<person name="Meco G."/>
<person name="Denefle P."/>
<person name="Agid Y."/>
<person name="Brice A."/>
</authorList>
<dbReference type="PubMed" id="10072423"/>
<dbReference type="DOI" id="10.1093/hmg/8.4.567"/>
</citation>
<scope>VARIANTS PARK2 ASN-161; CYS-256; TRP-275 AND ASN-415</scope>
<scope>VARIANTS ASN-167; LEU-380 AND ASN-394</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1999" name="NeuroReport" volume="10" first="2735" last="2739">
<title>Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease.</title>
<authorList>
<person name="Satoh J."/>
<person name="Kuroda Y."/>
</authorList>
<dbReference type="PubMed" id="10511432"/>
<dbReference type="DOI" id="10.1097/00001756-199909090-00008"/>
</citation>
<scope>VARIANT ASN-167</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2000" name="Ann. Neurol." volume="48" first="245" last="250">
<title>Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism.</title>
<authorList>
<person name="Maruyama M."/>
<person name="Ikeuchi T."/>
<person name="Saito M."/>
<person name="Ishikawa A."/>
<person name="Yuasa T."/>
<person name="Tanaka H."/>
<person name="Hayashi S."/>
<person name="Wakabayashi K."/>
<person name="Takahashi H."/>
<person name="Tsuji S."/>
</authorList>
<dbReference type="PubMed" id="10939576"/>
<dbReference type="DOI" id="10.1002/1531-8249(200008)48:2&lt;245::AID-ANA15>3.0.CO;2-2"/>
</citation>
<scope>VARIANT PARK2 PHE-431</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2000" name="Eur. Neurol." volume="44" first="90" last="93">
<title>Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan.</title>
<authorList>
<person name="Hu C.-J."/>
<person name="Sung S.-M."/>
<person name="Liu H.-C."/>
<person name="Lee C.-C."/>
<person name="Tsai C.-H."/>
<person name="Chang J.-G."/>
</authorList>
<dbReference type="PubMed" id="10965160"/>
<dbReference type="DOI" id="10.1159/000008203"/>
</citation>
<scope>VARIANTS ASN-167; TRP-366 AND LEU-380</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2000" name="N. Engl. J. Med." volume="342" first="1560" last="1567">
<title>Association between early-onset Parkinson's disease and mutations in the parkin gene.</title>
<authorList>
<person name="Luecking C.B."/>
<person name="Duerr A."/>
<person name="Bonifati V."/>
<person name="Vaughan J.R."/>
<person name="De Michele G."/>
<person name="Gasser T."/>
<person name="Harhangi B.S."/>
<person name="Meco G."/>
<person name="Denefle P."/>
<person name="Wood N.W."/>
<person name="Agid Y."/>
<person name="Brice A."/>
</authorList>
<dbReference type="PubMed" id="10824074"/>
<dbReference type="DOI" id="10.1056/NEJM200005253422103"/>
</citation>
<scope>VARIANTS PARK2 ASN-161; ASN-211; CYS-256; TRP-275; ASN-280; GLY-289; GLU-328; CYS-334; ASN-415 AND ASP-430</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Am. J. Hum. Genet." volume="68" first="617" last="626">
<title>Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects.</title>
<authorList>
<person name="Periquet M."/>
<person name="Luecking C.B."/>
<person name="Vaughan J.R."/>
<person name="Bonifati V."/>
<person name="Duerr A."/>
<person name="De Michele G."/>
<person name="Horstink M."/>
<person name="Farrer M."/>
<person name="Illarioshkin S.N."/>
<person name="Pollak P."/>
<person name="Borg M."/>
<person name="Brefel-Courbon C."/>
<person name="Denefle P."/>
<person name="Meco G."/>
<person name="Gasser T."/>
<person name="Breteler M.M."/>
<person name="Wood N.W."/>
<person name="Agid Y."/>
<person name="Brice A."/>
</authorList>
<dbReference type="PubMed" id="11179010"/>
<dbReference type="DOI" id="10.1086/318791"/>
</citation>
<scope>VARIANTS PARK2 ARG-211; TRP-275 AND ASP-430</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="1649" last="1656">
<title>The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism.</title>
<authorList>
<person name="Hedrich K."/>
<person name="Kann M."/>
<person name="Lanthaler A.J."/>
<person name="Dalski A."/>
<person name="Eskelson C."/>
<person name="Landt O."/>
<person name="Schwinger E."/>
<person name="Vieregge P."/>
<person name="Lang A.E."/>
<person name="Breakefield X.O."/>
<person name="Ozelius L.J."/>
<person name="Pramstaller P.P."/>
<person name="Klein C."/>
</authorList>
<dbReference type="PubMed" id="11487568"/>
<dbReference type="DOI" id="10.1093/hmg/10.16.1649"/>
</citation>
<scope>VARIANT PARK2 GLU-82</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2001" name="Neurosci. Lett." volume="298" first="87" last="90">
<title>A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile parkinsonism in a population from North West Colombia.</title>
<authorList>
<person name="Pineda-Trujillo N."/>
<person name="Carvajal-Carmona L.G."/>
<person name="Buritica O."/>
<person name="Moreno S."/>
<person name="Uribe C."/>
<person name="Pineda D."/>
<person name="Toro M."/>
<person name="Garcia F."/>
<person name="Arias W."/>
<person name="Bedoya G."/>
<person name="Lopera F."/>
<person name="Ruiz-Linares A."/>
</authorList>
<dbReference type="PubMed" id="11163284"/>
<dbReference type="DOI" id="10.1016/S0304-3940(00)01733-X"/>
</citation>
<scope>VARIANT PARK2 TYR-212</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="114" first="584" last="591">
<title>Complex relationship between parkin mutations and Parkinson disease.</title>
<authorList>
<consortium name="French Parkinson's disease genetics study group"/>
<consortium name="European consortium on genetic susceptibility on Parkinson's disease"/>
<person name="West A."/>
<person name="Periquet M."/>
<person name="Lincoln S."/>
<person name="Luecking C.B."/>
<person name="Nicholl D."/>
<person name="Bonifati V."/>
<person name="Rawal N."/>
<person name="Gasser T."/>
<person name="Lohmann E."/>
<person name="Deleuze J.-F."/>
<person name="Maraganore D."/>
<person name="Levey A."/>
<person name="Wood N.W."/>
<person name="Duerr A."/>
<person name="Hardy J."/>
<person name="Brice A."/>
<person name="Farrer M."/>
</authorList>
<dbReference type="PubMed" id="12116199"/>
<dbReference type="DOI" id="10.1002/ajmg.10525"/>
</citation>
<scope>VARIANTS PARK2 GLU-82; CYS-256; TRP-275; GLU-328 AND ARG-441</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="114" first="992" last="992">
<authorList>
<consortium name="French Parkinson's disease genetics study group"/>
<consortium name="European consortium on genetic susceptibility on Parkinson's disease"/>
<person name="West A."/>
<person name="Periquet M."/>
<person name="Lincoln S."/>
<person name="Luecking C.B."/>
<person name="Nicholl D."/>
<person name="Bonifati V."/>
<person name="Rawal N."/>
<person name="Gasser T."/>
<person name="Lohmann E."/>
<person name="Deleuze J.-F."/>
<person name="Maraganore D."/>
<person name="Levey A."/>
<person name="Wood N.W."/>
<person name="Duerr A."/>
<person name="Hardy J."/>
<person name="Brice A."/>
<person name="Farrer M.J."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2002" name="Ann. Neurol." volume="51" first="621" last="625">
<title>Role of parkin mutations in 111 community-based patients with early-onset parkinsonism.</title>
<authorList>
<person name="Kann M."/>
<person name="Jacobs H."/>
<person name="Mohrmann K."/>
<person name="Schumacher K."/>
<person name="Hedrich K."/>
<person name="Garrels J."/>
<person name="Wiegers K."/>
<person name="Schwinger E."/>
<person name="Pramstaller P.P."/>
<person name="Breakefield X.O."/>
<person name="Ozelius L.J."/>
<person name="Vieregge P."/>
<person name="Klein C."/>
</authorList>
<dbReference type="PubMed" id="12112109"/>
<dbReference type="DOI" id="10.1002/ana.10179"/>
</citation>
<scope>VARIANTS PARK2 LEU-37 AND PRO-351</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2002" name="Arch. Neurol." volume="59" first="966" last="970">
<title>Molecular findings in familial Parkinson disease in Spain.</title>
<authorList>
<person name="Hoenicka J."/>
<person name="Vidal L."/>
<person name="Morales B."/>
<person name="Ampuero I."/>
<person name="Jimenez-Jimenez F.J."/>
<person name="Berciano J."/>
<person name="del Ser T."/>
<person name="Jimenez A."/>
<person name="Ruiz P.G."/>
<person name="de Yebenes J.G."/>
</authorList>
<dbReference type="PubMed" id="12056932"/>
<dbReference type="DOI" id="10.1001/archneur.59.6.966"/>
</citation>
<scope>VARIANTS PARK2 GLU-56 AND TYR-212</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="489" last="492">
<title>Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families.</title>
<authorList>
<person name="Nichols W.C."/>
<person name="Pankratz N."/>
<person name="Uniacke S.K."/>
<person name="Pauciulo M.W."/>
<person name="Halter C."/>
<person name="Rudolph A."/>
<person name="Conneally P.M."/>
<person name="Foroud T."/>
</authorList>
<dbReference type="PubMed" id="12114481"/>
<dbReference type="DOI" id="10.1136/jmg.39.7.489"/>
</citation>
<scope>VARIANTS PARK2 ASN-211; TRP-275; ASP-430 AND LEU-437</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2002" name="J. Neurol. Neurosurg. Psych." volume="73" first="582" last="584">
<title>Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism.</title>
<authorList>
<person name="Munoz E."/>
<person name="Tolosa E."/>
<person name="Pastor P."/>
<person name="Marti M.J."/>
<person name="Valldeoriola F."/>
<person name="Campdelacreu J."/>
<person name="Oliva R."/>
</authorList>
<dbReference type="PubMed" id="12397156"/>
<dbReference type="DOI" id="10.1136/jnnp.73.5.582"/>
</citation>
<scope>VARIANT PARK2 MET-15</scope>
<scope>VARIANTS LEU-380 AND ASN-394</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2002" name="Neurology" volume="58" first="1239" last="1246">
<title>Evaluation of 50 probands with early-onset Parkinson's disease for parkin mutations.</title>
<authorList>
<person name="Hedrich K."/>
<person name="Marder K."/>
<person name="Harris J."/>
<person name="Kann M."/>
<person name="Lynch T."/>
<person name="Meija-Santana H."/>
<person name="Pramstaller P.P."/>
<person name="Schwinger E."/>
<person name="Bressman S.B."/>
<person name="Fahn S."/>
<person name="Klein C."/>
</authorList>
<dbReference type="PubMed" id="11971093"/>
<dbReference type="DOI" id="10.1212/WNL.58.8.1239"/>
</citation>
<scope>VARIANTS PARK2 PRO-42; LEU-192; CYS-256; TRP-275; ASP-430 AND LEU-437</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2002" name="Zhonghua Yi Xue Yi Chuan Xue Za Zhi" volume="19" first="409" last="411">
<title>A new point mutation on exon 2 of parkin gene in Parkinson's disease.</title>
<authorList>
<person name="Xu Y."/>
<person name="Liu Z."/>
<person name="Wang Y."/>
<person name="Tao E."/>
<person name="Chen G."/>
<person name="Chen B."/>
</authorList>
<dbReference type="PubMed" id="12362318"/>
</citation>
<scope>VARIANT PARK2 PRO-46</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2003" name="Ann. Neurol." volume="53" first="624" last="629">
<title>Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.</title>
<authorList>
<person name="Oliveira S.A."/>
<person name="Scott W.K."/>
<person name="Martin E.R."/>
<person name="Nance M.A."/>
<person name="Watts R.L."/>
<person name="Hubble J.P."/>
<person name="Koller W.C."/>
<person name="Pahwa R."/>
<person name="Stern M.B."/>
<person name="Hiner B.C."/>
<person name="Ondo W.G."/>
<person name="Allen F.H. Jr."/>
<person name="Scott B.L."/>
<person name="Goetz C.G."/>
<person name="Small G.W."/>
<person name="Mastaglia F."/>
<person name="Stajich J.M."/>
<person name="Zhang F."/>
<person name="Booze M.W."/>
<person name="Winn M.P."/>
<person name="Middleton L.T."/>
<person name="Haines J.L."/>
<person name="Pericak-Vance M.A."/>
<person name="Vance J.M."/>
</authorList>
<dbReference type="PubMed" id="12730996"/>
<dbReference type="DOI" id="10.1002/ana.10524"/>
</citation>
<scope>VARIANTS PARK2 GLN-33; GLU-82; ASP-430 AND LEU-437</scope>
<scope>VARIANTS PARK TYR-253; CYS-256; TRP-275 AND ASN-280</scope>
<scope>VARIANTS LEU-380 AND ASN-394</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2003" name="Neurology" volume="60" first="796" last="801">
<title>Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease.</title>
<authorList>
<person name="Foroud T."/>
<person name="Uniacke S.K."/>
<person name="Liu L."/>
<person name="Pankratz N."/>
<person name="Rudolph A."/>
<person name="Halter C."/>
<person name="Shults C."/>
<person name="Marder K."/>
<person name="Conneally P.M."/>
<person name="Nichols W.C."/>
</authorList>
<dbReference type="PubMed" id="12629236"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000049470.00180.07"/>
</citation>
<scope>VARIANTS PARK2 VAL-192; ASN-211; MET-240 AND LEU-437</scope>
<scope>VARIANT ASN-167</scope>
<scope>INVOLVEMENT IN LATE-ONSET PARK</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2003" name="Parkinsonism Relat. Disord." volume="9" first="309" last="312">
<title>Parkin mutations are rare in patients with young-onset parkinsonism in a US population.</title>
<authorList>
<person name="Chen R."/>
<person name="Gosavi N.S."/>
<person name="Langston J.W."/>
<person name="Chan P."/>
</authorList>
<dbReference type="PubMed" id="12781599"/>
</citation>
<scope>VARIANTS HIS-100; SER-271 AND SER-339</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2005" name="Mov. Disord." volume="20" first="424" last="431">
<title>Novel parkin mutations detected in patients with early-onset Parkinson's disease.</title>
<authorList>
<consortium name="Italian Parkinson Genetics Network"/>
<person name="Bertoli-Avella A.M."/>
<person name="Giroud-Benitez J.L."/>
<person name="Akyol A."/>
<person name="Barbosa E."/>
<person name="Schaap O."/>
<person name="van der Linde H.C."/>
<person name="Martignoni E."/>
<person name="Lopiano L."/>
<person name="Lamberti P."/>
<person name="Fincati E."/>
<person name="Antonini A."/>
<person name="Stocchi F."/>
<person name="Montagna P."/>
<person name="Squitieri F."/>
<person name="Marini P."/>
<person name="Abbruzzese G."/>
<person name="Fabbrini G."/>
<person name="Marconi R."/>
<person name="Dalla Libera A."/>
<person name="Trianni G."/>
<person name="Guidi M."/>
<person name="De Gaetano A."/>
<person name="Boff Maegawa G."/>
<person name="De Leo A."/>
<person name="Gallai V."/>
<person name="de Rosa G."/>
<person name="Vanacore N."/>
<person name="Meco G."/>
<person name="van Duijn C.M."/>
<person name="Oostra B.A."/>
<person name="Heutink P."/>
<person name="Bonifati V."/>
</authorList>
<dbReference type="PubMed" id="15584030"/>
<dbReference type="DOI" id="10.1002/mds.20343"/>
</citation>
<scope>VARIANTS PARK2 PRO-42; CYS-402; ASN-415 AND ARG-418</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2010" name="J. Cell Biol." volume="189" first="211" last="221">
<title>PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy.</title>
<authorList>
<person name="Matsuda N."/>
<person name="Sato S."/>
<person name="Shiba K."/>
<person name="Okatsu K."/>
<person name="Saisho K."/>
<person name="Gautier C.A."/>
<person name="Sou Y.S."/>
<person name="Saiki S."/>
<person name="Kawajiri S."/>
<person name="Sato F."/>
<person name="Kimura M."/>
<person name="Komatsu M."/>
<person name="Hattori N."/>
<person name="Tanaka K."/>
</authorList>
<dbReference type="PubMed" id="20404107"/>
<dbReference type="DOI" id="10.1083/jcb.200910140"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ASN-211; ARG-240; ASN-280 AND GLU-328</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2012" name="Mov. Disord." volume="27" first="1522" last="1529">
<title>Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.</title>
<authorList>
<person name="Kilarski L.L."/>
<person name="Pearson J.P."/>
<person name="Newsway V."/>
<person name="Majounie E."/>
<person name="Knipe M.D."/>
<person name="Misbahuddin A."/>
<person name="Chinnery P.F."/>
<person name="Burn D.J."/>
<person name="Clarke C.E."/>
<person name="Marion M.H."/>
<person name="Lewthwaite A.J."/>
<person name="Nicholl D.J."/>
<person name="Wood N.W."/>
<person name="Morrison K.E."/>
<person name="Williams-Gray C.H."/>
<person name="Evans J.R."/>
<person name="Sawcer S.J."/>
<person name="Barker R.A."/>
<person name="Wickremaratchi M.M."/>
<person name="Ben-Shlomo Y."/>
<person name="Williams N.M."/>
<person name="Morris H.R."/>
</authorList>
<dbReference type="PubMed" id="22956510"/>
<dbReference type="DOI" id="10.1002/mds.25132"/>
</citation>
<scope>VARIANT PARK2 TRP-275</scope>
</reference>
<comment type="function">
<text evidence="13 16 20 22 31 34 39 41 43 48 49 50 51 53 54 57 58 59 60 62 64 66 68 69 70 71 72 73">Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins, such as BCL2, SYT11, CCNE1, GPR37, RHOT1/MIRO1, MFN1, MFN2, STUB1, SNCAIP, SEPT5, TOMM20, USP30, ZNF746 and AIMP2 (PubMed:10973942, PubMed:10888878, PubMed:11431533, PubMed:12150907, PubMed:12628165, PubMed:16135753, PubMed:21376232, PubMed:23754282, PubMed:23620051, PubMed:24660806, PubMed:24751536). Mediates monoubiquitination as well as 'Lys-6', 'Lys-11', 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context (PubMed:19229105, PubMed:20889974, PubMed:25621951). Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation (PubMed:17846173, PubMed:19229105). Mediates 'Lys-63'-linked polyubiquitination of a 22 kDa O-linked glycosylated isoform of SNCAIP, possibly playing a role in Lewy-body formation (PubMed:11590439, PubMed:11431533, PubMed:19229105, PubMed:11590439, PubMed:15728840). Mediates monoubiquitination of BCL2, thereby acting as a positive regulator of autophagy (PubMed:20889974). Promotes the autophagic degradation of dysfunctional depolarized mitochondria (mitophagy) by promoting the ubiquitination of mitochondrial proteins such as TOMM20, RHOT1/MIRO1 and USP30 (PubMed:19029340, PubMed:19966284, PubMed:23620051, PubMed:24896179, PubMed:25527291). Preferentially assembles 'Lys-6'-, 'Lys-11'- and 'Lys-63'-linked polyubiquitin chains following mitochondrial damage, leading to mitophagy (PubMed:25621951). Mediates 'Lys-48'-linked polyubiquitination of ZNF746, followed by degradation of ZNF746 by the proteasome; possibly playing a role in the regulation of neuron death (PubMed:21376232). Limits the production of reactive oxygen species (ROS). Regulates cyclin-E during neuronal apoptosis. In collaboration with CHPF isoform 2, may enhance cell viability and protect cells from oxidative stress (PubMed:22082830). Independently of its ubiquitin ligase activity, protects from apoptosis by the transcriptional repression of p53/TP53 (PubMed:19801972). May protect neurons against alpha synuclein toxicity, proteasomal dysfunction, GPR37 accumulation, and kainate-induced excitotoxicity (PubMed:11439185). May play a role in controlling neurotransmitter trafficking at the presynaptic terminal and in calcium-dependent exocytosis. May represent a tumor suppressor gene.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="63 65 68 69 70 72">In the autoinhibited state the side chain of Phe-463 inserts into a hydrophobic groove in RING-0, occluding the ubiquitin acceptor site Cys-431, whereas the REP repressor element binds RING-1 and blocks its E2-binding site (PubMed:23727886, PubMed:23770887). Activation of PARK2 requires 2 steps: (1) phosphorylation at Ser-65 by PINK1 and (2) binding to phosphorylated ubiquitin, leading to unlock repression of the catalytic Cys-431 by the RING-0 region via an allosteric mechanism and converting PARK2 to its fully-active form (PubMed:24660806, PubMed:24784582, PubMed:25527291). According to another report, phosphorylation at Ser-65 by PINK1 is not essential for activation and only binding to phosphorylated ubiquitin is essential to unlock repression (PubMed:24751536).</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="17 22 28 31 33 37 38 41 42 43 44 45 46 47 49 51 54 56 57 58 59 60 62 66 67">Forms an E3 ubiquitin ligase complex with UBE2L3 or UBE2L6. Mediates 'Lys-63'-linked polyubiquitination by associating with UBE2V1. Part of a SCF-like complex, consisting of PARK2, CUL1 and FBXW7. Interacts with SNCAIP. Binds to the C2A and C2B domains of SYT11. Interacts and regulates the turnover of SEPT5. Part of a complex, including STUB1, HSP70 and GPR37. The amount of STUB1 in the complex increases during ER stress. STUB1 promotes the dissociation of HSP70 from PARK2 and GPR37, thus facilitating PARK2-mediated GPR37 ubiquitination. HSP70 transiently associates with unfolded GPR37 and inhibits the E3 activity of PARK2, whereas, STUB1 enhances the E3 activity of PARK2 through promotion of dissociation of HSP70 from PARK2-GPR37 complexes. Interacts with PSMD4 and PACRG. Interacts with LRRK2. Interacts with RANBP2. Interacts with SUMO1 but not SUMO2, which promotes nuclear localization and autoubiquitination. Interacts (via first RING-type domain) with AIMP2 (via N-terminus). Interacts with PSMA7 and RNF41. Interacts with PINK1. Interacts with CHPF, the interaction with isoform 2 may facilitate PARK2 transport into the mitochondria. Interacts with MFN2 (phosphorylated), promotes PARK2 localization in dysfunctional depolarized mitochondria. Interacts with FBXO7; this promotes translocation to dysfunctional depolarized mitochondria. Interacts with heat shock protein 70 family members, including HSPA1L, HSPA1A and HSPA8; interaction HSPA1L promotes translocation to damaged mitochondria. Interacts with BAG4 and, to a lesser extent, BAG5; interaction with BAG4 inhibits translocation to damaged mitochondria. Forms a complex with PINK1 and PARK7 (PubMed:19229105).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-716346"/>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-6858513">
<id>Q99IB8</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-9684323">
<id>P54252-2</id>
<label>ATXN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-9029620">
<id>Q8IZ52-2</id>
<label>CHPF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-1161222">
<id>Q9Y3I1</id>
<label>FBXO7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-9102965">
<id>Q9Y3I1-1</id>
<label>FBXO7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-5323863">
<id>Q5S007</id>
<label>LRRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-359462">
<id>Q16342</id>
<label>PDCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-2846068">
<id>Q9BXM7</id>
<label>PINK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-973138">
<id>P49792</id>
<label>RANBP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-1396430">
<id>Q8IXI2</id>
<label>RHOT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-772125">
<id>Q9Z2Q6</id>
<label>Sept5</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-358993">
<id>Q15645</id>
<label>TRIP13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716346"/>
<interactant intactId="EBI-3862525">
<id>Q6NUN9</id>
<label>ZNF746</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="51">Cytoplasm</location>
<location evidence="51">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="51">Mitochondrion</location>
</subcellularLocation>
<text>Mainly localizes in the cytosol. Co-localizes with SYT11 in neutrites. Co-localizes with SNCAIP in brainstem Lewy bodies. Mitochondrial localization gradually increases with cellular growth. Also relocates to dysfunctional mitochondria that have lost the mitochondrial membrane potential; recruitment to mitochondria is PINK1-dependent.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O60260-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O60260-2</id>
<name>2</name>
<name>SV5DEL</name>
<sequence type="described" ref="VSP_011707"/>
</isoform>
<isoform>
<id>O60260-3</id>
<name>3</name>
<sequence type="described" ref="VSP_011706 VSP_011709 VSP_011710"/>
</isoform>
<isoform>
<id>O60260-4</id>
<name>4</name>
<sequence type="described" ref="VSP_011705"/>
</isoform>
<isoform>
<id>O60260-5</id>
<name>5</name>
<sequence type="described" ref="VSP_011708 VSP_011711 VSP_011712"/>
</isoform>
<isoform>
<id>O60260-6</id>
<name>6</name>
<sequence type="described" ref="VSP_041563"/>
</isoform>
<isoform>
<id>O60260-7</id>
<name>7</name>
<name>SV5,9DEL</name>
<sequence type="described" ref="VSP_011707 VSP_053651"/>
</isoform>
<isoform>
<id>O60260-8</id>
<name>8</name>
<name>SV9DEL</name>
<sequence type="described" ref="VSP_053651"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="52">Highly expressed in the brain including the substantia nigra. Expressed in heart, testis and skeletal muscle. Expression is down-regulated or absent in tumor biopsies, and absent in the brain of PARK2 patients. Overexpression protects dopamine neurons from kainate-mediated apoptosis. Found in serum (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="53">The ubiquitin-like domain binds the PSMD4 subunit of 26S proteasomes.</text>
</comment>
<comment type="domain">
<text evidence="53">The RING-type 1 zinc finger domain is required to repress p53/TP53 transcription.</text>
</comment>
<comment type="PTM">
<text evidence="51">Auto-ubiquitinates in an E2-dependent manner leading to its own degradation (PubMed:19229105). Also polyubiquitinated by RNF41 for proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="39">S-nitrosylated. The inhibition of PARK2 ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in PD by impairing the ubiquitination of PARK2 substrates.</text>
</comment>
<comment type="PTM">
<text evidence="64 68 70">Phosphorylation at Ser-65 by PINK1 contributes to activate PARK2 activity. It is however not sufficient and requires binding to phosphorylated ubiquitin as well.</text>
</comment>
<comment type="disease" evidence="32 35">
<disease id="DI-02134">
<name>Parkinson disease</name>
<acronym>PARK</acronym>
<description>A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.</description>
<dbReference type="MIM" id="168600"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry. Heterozygous mutations act as susceptibility alleles for late-onset Parkinson disease (PubMed:12730996 and PubMed:12629236).</text>
</comment>
<comment type="disease" evidence="10 12 14 18 19 21 23 24 25 26 27 29 30 32 35 40 61 74 75">
<disease id="DI-01238">
<name>Parkinson disease 2</name>
<acronym>PARK2</acronym>
<description>A neurodegenerative disorder characterized by bradykinesia, rigidity, postural instability, tremor, and onset usually before 40. It differs from classic Parkinson disease by early DOPA-induced dyskinesia, diurnal fluctuation of the symptoms, sleep benefit, dystonia and hyper-reflexia. Dementia is absent. Pathologically, patients show loss of dopaminergic neurons in the substantia nigra, similar to that seen in Parkinson disease; however, Lewy bodies (intraneuronal accumulations of aggregated proteins) are absent.</description>
<dbReference type="MIM" id="600116"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Defects in PARK2 may be involved in the development and/or progression of ovarian cancer.</text>
</comment>
<comment type="miscellaneous">
<text>The parkin locus (PRKN), adjacent to the 6q telomere is hyper-recombinable and lies within FRA6E, the third most common fragile site in tumor tissue.</text>
</comment>
<comment type="miscellaneous">
<text evidence="81">Members of the RBR family are atypical E3 ligases. They interact with the E2 conjugating enzyme UBE2L3 and function like HECT-type E3 enzymes: they bind E2s via the first RING domain, but require an obligate trans-thiolation step during the ubiquitin transfer, requiring a conserved cysteine residue in the second RING domain (PubMed:21532592).</text>
</comment>
<comment type="similarity">
<text evidence="80">Belongs to the RBR family. Parkin subfamily.</text>
</comment>
<comment type="similarity">
<text evidence="80">Contains 1 IBR-type zinc finger.</text>
</comment>
<comment type="similarity">
<text evidence="80">Contains 3 RING-type zinc fingers.</text>
</comment>
<comment type="similarity">
<text evidence="9">Contains 1 ubiquitin-like domain.</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="http://web.expasy.org/spotlight/back_issues/131"/>
<text>Life's tremors - Issue 131 of September 2011</text>
</comment>
<dbReference type="EC" id="6.3.2.-"/>
<dbReference type="EMBL" id="AB009973">
<property type="protein sequence ID" value="BAA25751.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF375726">
<property type="protein sequence ID" value="ABN46990.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF381282">
<property type="protein sequence ID" value="AAM21457.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF381283">
<property type="protein sequence ID" value="AAM21458.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF381286">
<property type="protein sequence ID" value="AAM21461.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU345839">
<property type="protein sequence ID" value="ADB90270.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU345840">
<property type="protein sequence ID" value="ADB90271.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU361467">
<property type="protein sequence ID" value="ADB91979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292590">
<property type="protein sequence ID" value="BAF85279.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445215">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035697">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL132982">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000886">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000887">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001576">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001577">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001578">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP003699">
<property type="protein sequence ID" value="CAH73681.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035697">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL132982">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445215">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000886">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000887">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001576">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001577">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001578">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP003699">
<property type="protein sequence ID" value="CAI21385.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL132982">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035697">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445215">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000886">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000887">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001576">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001577">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001578">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP003699">
<property type="protein sequence ID" value="CAI23601.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW47573.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW47574.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC022014">
<property type="protein sequence ID" value="AAH22014.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY564225">
<property type="protein sequence ID" value="AAS88422.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5281.1">
<molecule id="O60260-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5282.1">
<molecule id="O60260-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5283.1">
<molecule id="O60260-6"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004553.2">
<molecule id="O60260-1"/>
<property type="nucleotide sequence ID" value="NM_004562.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_054642.2">
<molecule id="O60260-2"/>
<property type="nucleotide sequence ID" value="NM_013987.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_054643.2">
<molecule id="O60260-6"/>
<property type="nucleotide sequence ID" value="NM_013988.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.132954"/>
<dbReference type="PDB" id="1IYF">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-76"/>
</dbReference>
<dbReference type="PDB" id="2JMO">
<property type="method" value="NMR"/>
<property type="chains" value="A=308-384"/>
</dbReference>
<dbReference type="PDB" id="4BM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=137-465"/>
</dbReference>
<dbReference type="PDB" id="4I1F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=141-465"/>
</dbReference>
<dbReference type="PDB" id="4I1H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=141-465"/>
</dbReference>
<dbReference type="PDB" id="5C1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A/B=1-465"/>
</dbReference>
<dbReference type="PDB" id="5C23">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A/B=1-465"/>
</dbReference>
<dbReference type="PDB" id="5C9V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=137-465"/>
</dbReference>
<dbReference type="PDBsum" id="1IYF"/>
<dbReference type="PDBsum" id="2JMO"/>
<dbReference type="PDBsum" id="4BM9"/>
<dbReference type="PDBsum" id="4I1F"/>
<dbReference type="PDBsum" id="4I1H"/>
<dbReference type="PDBsum" id="5C1Z"/>
<dbReference type="PDBsum" id="5C23"/>
<dbReference type="PDBsum" id="5C9V"/>
<dbReference type="ProteinModelPortal" id="O60260"/>
<dbReference type="SMR" id="O60260">
<property type="residue range" value="1-465"/>
</dbReference>
<dbReference type="BioGrid" id="111105">
<property type="interactions" value="402"/>
</dbReference>
<dbReference type="DIP" id="DIP-37655N"/>
<dbReference type="IntAct" id="O60260">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="MINT" id="MINT-1351124"/>
<dbReference type="STRING" id="9606.ENSP00000355865"/>
<dbReference type="iPTMnet" id="O60260"/>
<dbReference type="PhosphoSite" id="O60260"/>
<dbReference type="BioMuta" id="PARK2"/>
<dbReference type="PaxDb" id="O60260"/>
<dbReference type="PRIDE" id="O60260"/>
<dbReference type="DNASU" id="5071"/>
<dbReference type="Ensembl" id="ENST00000338468">
<molecule id="O60260-4"/>
<property type="protein sequence ID" value="ENSP00000343589"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366894">
<molecule id="O60260-4"/>
<property type="protein sequence ID" value="ENSP00000355860"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366896">
<molecule id="O60260-6"/>
<property type="protein sequence ID" value="ENSP00000355862"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366897">
<molecule id="O60260-2"/>
<property type="protein sequence ID" value="ENSP00000355863"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366898">
<molecule id="O60260-1"/>
<property type="protein sequence ID" value="ENSP00000355865"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000479615">
<molecule id="O60260-3"/>
<property type="protein sequence ID" value="ENSP00000434414"/>
<property type="gene ID" value="ENSG00000185345"/>
</dbReference>
<dbReference type="GeneID" id="5071"/>
<dbReference type="KEGG" id="hsa:5071"/>
<dbReference type="UCSC" id="uc003qtx.4">
<molecule id="O60260-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc003qty.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc010kke.1">
<molecule id="O60260-5"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5071"/>
<dbReference type="GeneCards" id="PARK2"/>
<dbReference type="GeneReviews" id="PARK2"/>
<dbReference type="HGNC" id="HGNC:8607">
<property type="gene designation" value="PARK2"/>
</dbReference>
<dbReference type="HPA" id="CAB016257"/>
<dbReference type="MalaCards" id="PARK2"/>
<dbReference type="MIM" id="168600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600116">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602544">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60260"/>
<dbReference type="Orphanet" id="2828">
<property type="disease" value="Young adult-onset Parkinsonism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA32942"/>
<dbReference type="eggNOG" id="KOG0006">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YG4B">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000011034"/>
<dbReference type="HOGENOM" id="HOG000013184"/>
<dbReference type="HOVERGEN" id="HBG053682"/>
<dbReference type="InParanoid" id="O60260"/>
<dbReference type="KO" id="K04556"/>
<dbReference type="OMA" id="GGEKDFA"/>
<dbReference type="OrthoDB" id="EOG738054"/>
<dbReference type="PhylomeDB" id="O60260"/>
<dbReference type="TreeFam" id="TF314529"/>
<dbReference type="BRENDA" id="2.3.2.B10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5205685">
<property type="pathway name" value="Pink/Parkin Mediated Mitophagy"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SignaLink" id="O60260"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="EvolutionaryTrace" id="O60260"/>
<dbReference type="GeneWiki" id="Parkin_(ligase)"/>
<dbReference type="GenomeRNAi" id="5071"/>
<dbReference type="NextBio" id="19538"/>
<dbReference type="PRO" id="PR:O60260"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="O60260"/>
<dbReference type="CleanEx" id="HS_PARK2"/>
<dbReference type="ExpressionAtlas" id="O60260">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O60260">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016235">
<property type="term" value="C:aggresome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097413">
<property type="term" value="C:Lewy body"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:1990452">
<property type="term" value="C:Parkin-FBXW7-Cul1 ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097602">
<property type="term" value="F:cullin family protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990444">
<property type="term" value="F:F-box domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001664">
<property type="term" value="F:G-protein coupled receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031072">
<property type="term" value="F:heat shock protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030544">
<property type="term" value="F:Hsp70 protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016874">
<property type="term" value="F:ligase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030165">
<property type="term" value="F:PDZ domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043274">
<property type="term" value="F:phospholipase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904264">
<property type="term" value="F:ubiquitin protein ligase activity involved in ERAD pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990381">
<property type="term" value="F:ubiquitin-specific protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008344">
<property type="term" value="P:adult locomotory behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070842">
<property type="term" value="P:aggresome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903351">
<property type="term" value="P:cellular response to dopamine"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071287">
<property type="term" value="P:cellular response to manganese ion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097237">
<property type="term" value="P:cellular response to toxic substance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034620">
<property type="term" value="P:cellular response to unfolded protein"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042417">
<property type="term" value="P:dopamine metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051583">
<property type="term" value="P:dopamine uptake involved in synaptic transmission"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036503">
<property type="term" value="P:ERAD pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010994">
<property type="term" value="P:free ubiquitin chain polymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007612">
<property type="term" value="P:learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016236">
<property type="term" value="P:macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000423">
<property type="term" value="P:macromitophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000266">
<property type="term" value="P:mitochondrial fission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007005">
<property type="term" value="P:mitochondrion organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000422">
<property type="term" value="P:mitophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098779">
<property type="term" value="P:mitophagy in response to mitochondrial depolarization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044828">
<property type="term" value="P:negative regulation by host of viral genome replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0032232">
<property type="term" value="P:negative regulation of actin filament bundle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060548">
<property type="term" value="P:negative regulation of cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902236">
<property type="term" value="P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903382">
<property type="term" value="P:negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033132">
<property type="term" value="P:negative regulation of glucokinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046329">
<property type="term" value="P:negative regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010637">
<property type="term" value="P:negative regulation of mitochondrial fusion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903202">
<property type="term" value="P:negative regulation of oxidative stress-induced cell death"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903377">
<property type="term" value="P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902283">
<property type="term" value="P:negative regulation of primary amine oxidase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090201">
<property type="term" value="P:negative regulation of release of cytochrome c from mitochondria"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904049">
<property type="term" value="P:negative regulation of spontaneous neurotransmitter secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070050">
<property type="term" value="P:neuron cellular homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042415">
<property type="term" value="P:norepinephrine metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903861">
<property type="term" value="P:positive regulation of dendrite extension"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043388">
<property type="term" value="P:positive regulation of DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090141">
<property type="term" value="P:positive regulation of mitochondrial fission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010636">
<property type="term" value="P:positive regulation of mitochondrial fusion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051582">
<property type="term" value="P:positive regulation of neurotransmitter uptake"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903378">
<property type="term" value="P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901800">
<property type="term" value="P:positive regulation of proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902530">
<property type="term" value="P:positive regulation of protein linear polyubiquitination"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903265">
<property type="term" value="P:positive regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010498">
<property type="term" value="P:proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070979">
<property type="term" value="P:protein K11-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044314">
<property type="term" value="P:protein K27-linked ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035519">
<property type="term" value="P:protein K29-linked ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070936">
<property type="term" value="P:protein K48-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0085020">
<property type="term" value="P:protein K6-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070534">
<property type="term" value="P:protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070585">
<property type="term" value="P:protein localization to mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006513">
<property type="term" value="P:protein monoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900407">
<property type="term" value="P:regulation of cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042053">
<property type="term" value="P:regulation of dopamine metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014059">
<property type="term" value="P:regulation of dopamine secretion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010906">
<property type="term" value="P:regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032368">
<property type="term" value="P:regulation of lipid transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051881">
<property type="term" value="P:regulation of mitochondrial membrane potential"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010821">
<property type="term" value="P:regulation of mitochondrion organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903146">
<property type="term" value="P:regulation of mitophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903214">
<property type="term" value="P:regulation of protein targeting to mitochondrion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031396">
<property type="term" value="P:regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000377">
<property type="term" value="P:regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902803">
<property type="term" value="P:regulation of synaptic vesicle transport"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034976">
<property type="term" value="P:response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001964">
<property type="term" value="P:startle response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035249">
<property type="term" value="P:synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0055069">
<property type="term" value="P:zinc ion homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR031127">
<property type="entry name" value="E3_UB_ligase_RBR"/>
</dbReference>
<dbReference type="InterPro" id="IPR002867">
<property type="entry name" value="IBR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003977">
<property type="entry name" value="Parkin"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000626">
<property type="entry name" value="Ubiquitin_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11685">
<property type="entry name" value="PTHR11685"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01485">
<property type="entry name" value="IBR"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00240">
<property type="entry name" value="ubiquitin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037880">
<property type="entry name" value="Parkin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01475">
<property type="entry name" value="PARKIN"/>
</dbReference>
<dbReference type="SMART" id="SM00647">
<property type="entry name" value="IBR"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00213">
<property type="entry name" value="UBQ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50053">
<property type="entry name" value="UBIQUITIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0436">Ligase</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase parkin" id="PRO_0000058576">
<location>
<begin position="1"/>
<end position="465"/>
</location>
</feature>
<feature type="domain" description="Ubiquitin-like" evidence="9">
<location>
<begin position="1"/>
<end position="76"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type 0; atypical">
<location>
<begin position="141"/>
<end position="225"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type 1; atypical">
<location>
<begin position="238"/>
<end position="293"/>
</location>
</feature>
<feature type="zinc finger region" description="IBR-type">
<location>
<begin position="313"/>
<end position="377"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type 2">
<location>
<begin position="418"/>
<end position="449"/>
</location>
</feature>
<feature type="region of interest" description="SYT11 binding 1" evidence="37">
<location>
<begin position="204"/>
<end position="238"/>
</location>
</feature>
<feature type="region of interest" description="SYT11 binding 2" evidence="37">
<location>
<begin position="257"/>
<end position="293"/>
</location>
</feature>
<feature type="region of interest" description="REP" evidence="7">
<location>
<begin position="378"/>
<end position="410"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PINK1" evidence="64 68 70">
<location>
<position position="65"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_011705" evidence="78">
<location>
<begin position="1"/>
<end position="191"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_011706" evidence="78">
<location>
<begin position="1"/>
<end position="79"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_041563" evidence="80">
<location>
<begin position="58"/>
<end position="206"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 7." id="VSP_011707" evidence="77 79">
<location>
<begin position="179"/>
<end position="206"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_011708" evidence="76">
<original>V</original>
<variation>VGTGDTVVLRGALGGFRRGV</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_011709" evidence="78">
<original>AGCPNSL</original>
<variation>VCLLPGM</variation>
<location>
<begin position="291"/>
<end position="297"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_011710" evidence="78">
<location>
<begin position="298"/>
<end position="465"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7 and isoform 8." id="VSP_053651" evidence="79">
<location>
<begin position="312"/>
<end position="361"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_011711" evidence="76">
<original>FAFCREC</original>
<variation>YGQRRTK</variation>
<location>
<begin position="362"/>
<end position="368"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_011712" evidence="76">
<location>
<begin position="369"/>
<end position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019733" evidence="30">
<original>V</original>
<variation>M</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019734" evidence="35">
<original>R</original>
<variation>Q</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; dbSNP:rs148990138." id="VAR_019735" evidence="25">
<original>P</original>
<variation>L</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; induces a conformational change in the PSMD4-binding site of Ubl resulting in impaired proteasomal binding; Decreases ubiquitination and degradation." id="VAR_019736" evidence="13 20 23 40 51">
<original>R</original>
<variation>P</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019737" evidence="29">
<original>A</original>
<variation>P</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_070078" evidence="24">
<original>V</original>
<variation>E</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; dbSNP:rs55774500." id="VAR_019738" evidence="21 27 35">
<original>A</original>
<variation>E</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019739">
<original>A</original>
<variation>V</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_019740" evidence="36">
<original>Q</original>
<variation>H</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; severely compromises the mitochondrial localization; fails to stabilize BCL2; decreased binding to the TP53 promoter; abolishes TP53 transcriptional repression." id="VAR_019741" evidence="10 12 53 55 57">
<original>K</original>
<variation>N</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801474." id="VAR_019742" evidence="10 11 15 32">
<original>S</original>
<variation>N</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; unknown pathological significance; dbSNP:rs9456735." id="VAR_054107" evidence="23">
<original>M</original>
<variation>L</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; unknown pathological significance; dbSNP:rs9456735." id="VAR_019743" evidence="32">
<original>M</original>
<variation>V</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; severely compromises the mitochondrial localization; fails to stabilize BCL2." id="VAR_019744" evidence="12 26 32 55">
<original>K</original>
<variation>N</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019745" evidence="19">
<original>K</original>
<variation>R</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019746" evidence="18 24">
<original>C</original>
<variation>Y</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019747" evidence="32">
<original>T</original>
<variation>M</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impairs the ability to ubiquitinate SNCAIP and BCL2; loss of UBE2L3 binding; severely compromises the mitochondrial localization." id="VAR_019748" evidence="13 20 22 55 57 75">
<original>T</original>
<variation>R</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK; late onset." id="VAR_019749" evidence="35">
<original>C</original>
<variation>Y</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2 and PARK; at heterozygosity it is associated with late onset Parkinson disease; impairs the ability to ubiquitinate SNCAIP and ZNF746; decreased binding to the TP53 promoter; abolishes TP53 transcriptional repression; dbSNP:rs150562946." id="VAR_019750" evidence="10 12 22 23 27 35 53">
<original>R</original>
<variation>C</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_019751" evidence="36">
<original>R</original>
<variation>S</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2 and PARK; at heterozygosity it is associated with late onset Parkinson disease; impairs the ability to ubiquitinate SNCAIP; abolishes p53/TP53 transcriptional repression; dbSNP:rs34424986." id="VAR_019752" evidence="10 12 19 22 23 26 27 35 53 58 61">
<original>R</original>
<variation>W</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK; does not affect PINK-1 dependent localization to depolarized mitochondria." id="VAR_019753" evidence="12 35 55">
<original>D</original>
<variation>N</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019754">
<original>G</original>
<variation>R</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; fails to ubiquitinate SYT11; loses ability to bind SYT11; dbSNP:rs55961220." id="VAR_019755" evidence="12 37">
<original>C</original>
<variation>G</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease; unknown pathological significance." id="VAR_062672" evidence="52">
<original>Q</original>
<variation>R</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; does not affect PINK-1 dependent localization to depolarized mitochondria." id="VAR_019756" evidence="12 27 55">
<original>G</original>
<variation>E</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_019757" evidence="12">
<original>R</original>
<variation>C</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_019758" evidence="36">
<original>A</original>
<variation>S</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impairs folding of IBR domain." id="VAR_019759" evidence="25 47">
<original>T</original>
<variation>P</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56092260." id="VAR_019760" evidence="15">
<original>R</original>
<variation>W</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease; unknown pathological significance." id="VAR_062673" evidence="52">
<original>A</original>
<variation>T</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801582." id="VAR_019761" evidence="10 15 30 35">
<original>V</original>
<variation>L</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801334." id="VAR_019762" evidence="10 30 35">
<original>D</original>
<variation>N</variation>
<location>
<position position="394"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2." id="VAR_070079" evidence="40">
<original>R</original>
<variation>C</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impairs the ability to ubiquitinate SNCAIP; does not affect turnover of CDCRE1; impairs PINK1-dependent localization to dysfunctional depolarized mitochondria." id="VAR_019763" evidence="10 12 22 40 54">
<original>T</original>
<variation>N</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; decreased binding to the TP53 promoter; abolishes TP53 transcriptional repression; fails to ubiquitinate SYT11 but does not loose ability to bind SYT11." id="VAR_070080" evidence="37 40 53">
<original>C</original>
<variation>R</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impairs PINK1-dependent localization to dysfunctional depolarized mitochondria; impaired E3 ubiquitin-protein ligase toward ZNF746." id="VAR_019764" evidence="12 19 23 26 35 54 58">
<original>G</original>
<variation>D</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impaired E3 ubiquitin-protein ligase toward ZNF746 and BCL2." id="VAR_019765" evidence="14 57 58">
<original>C</original>
<variation>F</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; impaired E3 ubiquitin-protein ligase toward BCL2; dbSNP:rs149953814." id="VAR_019766" evidence="23 26 32 35 57">
<original>P</original>
<variation>L</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK2; decreased binding to the TP53 promoter; abolishes TP53 transcriptional repression." id="VAR_019767" evidence="27 53">
<original>C</original>
<variation>R</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant; still requires PINK1 for activation. PARK2 is activated in presence of phosphorylated ubiquitin." evidence="68 70">
<original>S</original>
<variation>E</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs folding of IBR domain." evidence="47">
<original>C</original>
<variation>S</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs the ability to ubiquitinate SNCAIP." evidence="22">
<original>C</original>
<variation>A</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs protein folding." evidence="47">
<original>C</original>
<variation>S</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased autoinhibition and increased E3 activity." evidence="70">
<original>W</original>
<variation>A</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs the ability of self-ubiquitination and to ubiquitinate SNCAIP." evidence="22 49">
<original>C</original>
<variation>A</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs the ability to ubiquitinate target proteins." evidence="22 63 65">
<original>C</original>
<variation>S</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired activity." evidence="63 65">
<original>H</original>
<variation>N</variation>
<variation>A</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired activity." evidence="63 65">
<original>E</original>
<variation>Q</variation>
<variation>A</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA25751 and 3; AAM21458/AAM21457." ref="1 3" evidence="80">
<original>S</original>
<variation>P</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAM21461." ref="2" evidence="80">
<original>CV</original>
<variation>MI</variation>
<location>
<begin position="289"/>
<end position="290"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAS88422." ref="9" evidence="80">
<original>A</original>
<variation>V</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="2"/>
<end position="11"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="13"/>
<end position="16"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="23"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="41"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="66"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="147"/>
<end position="150"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="156"/>
<end position="166"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="167"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="174"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="183"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="192"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="205"/>
<end position="212"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="239"/>
<end position="241"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="246"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="257"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="261"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="301"/>
<end position="307"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="309"/>
<end position="326"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="348"/>
<end position="351"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="366"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="395"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="414"/>
<end position="417"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="429"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="433"/>
<end position="435"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="439"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="444"/>
<end position="446"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="455"/>
<end position="461"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IYF"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JMO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BM9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I1F"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I1H"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5C1Z"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JK66"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00214"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10072423"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10511432"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10824074"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10888878"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10939576"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10965160"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973942"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11078524"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11163284"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11179010"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11431533"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11487568"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11590439"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971093"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12056932"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12112109"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12114481"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12116199"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12150907"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12362318"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12397156"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628165"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12629236"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12634850"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12719539"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12730996"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12781599"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12925569"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532270"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15105460"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15584030"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15728840"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15987638"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16135753"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16332688"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16352719"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16955485"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17360614"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17846173"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18541373"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19029340"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19229105"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19501131"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19801972"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19966284"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20404107"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20798600"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20889974"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21376232"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21532592"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22082830"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22956510"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23620051"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23727886"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23754282"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23770887"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23933751"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24270810"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24660806"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24751536"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24784582"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24896179"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25527291"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25621951"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9560156"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9731209"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9560156"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="79" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="80" type="ECO:0000305"/>
<evidence key="81" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21532592"/>
</source>
</evidence>
<sequence length="465" mass="51641" checksum="9A8BB802A3FC84C3" modified="2006-10-17" version="2">
MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCD
LDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLA
VILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGP
SCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCIT
CTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKE
LHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGC
GFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPR
CHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2016-01-20" version="142">
<accession>Q9Y6H5</accession>
<accession>D3DSZ1</accession>
<accession>Q05BS1</accession>
<accession>Q1PSC2</accession>
<accession>Q49AC6</accession>
<accession>Q504U9</accession>
<accession>Q6L984</accession>
<accession>Q6L985</accession>
<accession>Q6L986</accession>
<accession>Q9HC59</accession>
<name>SNCAP_HUMAN</name>
<protein>
<recommendedName>
<fullName>Synphilin-1</fullName>
<shortName>Sph1</shortName>
</recommendedName>
<alternativeName>
<fullName>Alpha-synuclein-interacting protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SNCAIP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="110" last="114">
<title>Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.</title>
<authorList>
<person name="Engelender S."/>
<person name="Kaminsky Z."/>
<person name="Guo X."/>
<person name="Sharp A.H."/>
<person name="Amaravi R.K."/>
<person name="Kleiderlein J.J."/>
<person name="Margolis R.L."/>
<person name="Troncoso J.C."/>
<person name="Lanahan A."/>
<person name="Worley P.F."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="10319874"/>
<dbReference type="DOI" id="10.1038/8820"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ALA-44</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mamm. Genome" volume="11" first="763" last="766">
<title>Organization of the human synphilin-1 gene, a candidate for Parkinson's disease.</title>
<authorList>
<person name="Engelender S."/>
<person name="Wanner T."/>
<person name="Kleiderlein J.J."/>
<person name="Wakabayashi K."/>
<person name="Tsuji S."/>
<person name="Takahashi H."/>
<person name="Ashworth R."/>
<person name="Margolis R.L."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="10967135"/>
<dbReference type="DOI" id="10.1007/s003350010123"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="5917" last="5922">
<title>Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients.</title>
<authorList>
<person name="Eyal A."/>
<person name="Szargel R."/>
<person name="Avraham E."/>
<person name="Liani E."/>
<person name="Haskin J."/>
<person name="Rott R."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="16595633"/>
<dbReference type="DOI" id="10.1073/pnas.0509707103"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification and characterization of alternatively spliced form of human synphilin-1.</title>
<authorList>
<person name="Lim M.K."/>
<person name="Ohsawa Y."/>
<person name="Kawamura T."/>
<person name="Asakawa S."/>
<person name="Takayanagi A."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4 AND 6)</scope>
<scope>VARIANT ALA-44</scope>
<source>
<tissue>Cerebellum</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 5)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="1144" last="1150">
<title>Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.</title>
<authorList>
<person name="Chung K.K.K."/>
<person name="Zhang Y."/>
<person name="Lim K.L."/>
<person name="Tanaka Y."/>
<person name="Huang H."/>
<person name="Gao J."/>
<person name="Ross C.A."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="11590439"/>
<dbReference type="DOI" id="10.1038/nm1001-1144"/>
</citation>
<scope>INTERACTION WITH PARK2</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="29106" last="29114">
<title>Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.</title>
<authorList>
<person name="Ito T."/>
<person name="Niwa J."/>
<person name="Hishikawa N."/>
<person name="Ishigaki S."/>
<person name="Doyu M."/>
<person name="Sobue G."/>
</authorList>
<dbReference type="PubMed" id="12750386"/>
<dbReference type="DOI" id="10.1074/jbc.M302763200"/>
</citation>
<scope>INTERACTION WITH RNF19A</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="51504" last="51514">
<title>Siah-1 facilitates ubiquitination and degradation of synphilin-1.</title>
<authorList>
<person name="Nagano Y."/>
<person name="Yamashita H."/>
<person name="Takahashi T."/>
<person name="Kishida S."/>
<person name="Nakamura T."/>
<person name="Iseki E."/>
<person name="Hattori N."/>
<person name="Mizuno Y."/>
<person name="Kikuchi A."/>
<person name="Matsumoto M."/>
</authorList>
<dbReference type="PubMed" id="14506261"/>
<dbReference type="DOI" id="10.1074/jbc.M306347200"/>
</citation>
<scope>INTERACTION WITH SIAH1</scope>
<scope>DEGRADATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="5500" last="5505">
<title>Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.</title>
<authorList>
<person name="Liani E."/>
<person name="Eyal A."/>
<person name="Avraham E."/>
<person name="Shemer R."/>
<person name="Szargel R."/>
<person name="Berg D."/>
<person name="Bornemann A."/>
<person name="Riess O."/>
<person name="Ross C.A."/>
<person name="Rott R."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="15064394"/>
<dbReference type="DOI" id="10.1073/pnas.0401081101"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
<scope>INTERACTION WITH SIAH1 AND SIAH2</scope>
<scope>MUTAGENESIS OF VAL-79 AND PRO-81</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11706" last="11716">
<title>Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.</title>
<authorList>
<person name="Szargel R."/>
<person name="Rott R."/>
<person name="Eyal A."/>
<person name="Haskin J."/>
<person name="Shani V."/>
<person name="Balan L."/>
<person name="Wolosker H."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="19224863"/>
<dbReference type="DOI" id="10.1074/jbc.M805990200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SIAH1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="FASEB J." volume="24" first="196" last="205">
<title>Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.</title>
<authorList>
<person name="Xie Y.Y."/>
<person name="Zhou C.J."/>
<person name="Zhou Z.R."/>
<person name="Hong J."/>
<person name="Che M.X."/>
<person name="Fu Q.S."/>
<person name="Song A.X."/>
<person name="Lin D.H."/>
<person name="Hu H.Y."/>
</authorList>
<dbReference type="PubMed" id="19762560"/>
<dbReference type="DOI" id="10.1096/fj.09-133082"/>
</citation>
<scope>STRUCTURE BY NMR OF 512-557</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>PROMOTION OF INCLUSION BODY FORMATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1223" last="1231">
<title>Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.</title>
<authorList>
<person name="Marx F.P."/>
<person name="Holzmann C."/>
<person name="Strauss K.M."/>
<person name="Li L."/>
<person name="Eberhardt O."/>
<person name="Gerhardt E."/>
<person name="Cookson M.R."/>
<person name="Hernandez D."/>
<person name="Farrer M.J."/>
<person name="Kachergus J."/>
<person name="Engelender S."/>
<person name="Ross C.A."/>
<person name="Berger K."/>
<person name="Schols L."/>
<person name="Schulz J.B."/>
<person name="Riess O."/>
<person name="Kruger R."/>
</authorList>
<dbReference type="PubMed" id="12761037"/>
<dbReference type="DOI" id="10.1093/hmg/ddg134"/>
</citation>
<scope>VARIANT CYS-621</scope>
<scope>CHARACTERIZATION OF VARIANT CYS-621</scope>
<scope>POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="BMC Med. Genet." volume="9" first="19" last="19">
<title>Genetic association study of synphilin-1 in idiopathic Parkinson's disease.</title>
<authorList>
<person name="Myhre R."/>
<person name="Klungland H."/>
<person name="Farrer M.J."/>
<person name="Aasly J.O."/>
</authorList>
<dbReference type="PubMed" id="18366718"/>
<dbReference type="DOI" id="10.1186/1471-2350-9-19"/>
</citation>
<scope>VARIANTS ALA-44; CYS-621 AND GLN-706</scope>
<scope>LACK OF ASSOCIATION WITH PARKINSON DISEASE</scope>
</reference>
<comment type="function">
<text evidence="10 12">Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1.</text>
</comment>
<comment type="subunit">
<text evidence="4 5 6 8 9 10 12 13 18">Homodimer (Probable). Heterodimer of isoform 1 and isoform 2 (Probable). Interacts with SIAH1, SIAH2, SNCA, RNF19A AND PARK2. Isoform 2 has a strong tendency to form aggregates and can sequester isoform 1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-717182"/>
<interactant intactId="EBI-717182"/>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9075374"/>
<interactant intactId="EBI-9075360">
<id>O60229-2</id>
<label>KALRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-717182"/>
<interactant intactId="EBI-985879">
<id>P37840</id>
<label>SNCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4 9 10 13">Cytoplasm</location>
</subcellularLocation>
<text>Detected in cytoplasmic inclusion bodies, together with SNCA.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6H5-1</id>
<name>1</name>
<name>1a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6H5-2</id>
<name>2</name>
<name>Synphilin-1A</name>
<sequence type="described" ref="VSP_038839 VSP_038842 VSP_038845"/>
</isoform>
<isoform>
<id>Q9Y6H5-3</id>
<name>3</name>
<sequence type="described" ref="VSP_038840 VSP_038845"/>
</isoform>
<isoform>
<id>Q9Y6H5-4</id>
<name>4</name>
<name>1b</name>
<sequence type="described" ref="VSP_038841"/>
</isoform>
<isoform>
<id>Q9Y6H5-5</id>
<name>5</name>
<sequence type="described" ref="VSP_038839 VSP_038842"/>
</isoform>
<isoform>
<id>Q9Y6H5-6</id>
<name>6</name>
<name>1c</name>
<sequence type="described" ref="VSP_038840 VSP_038843 VSP_038844"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4 10">Detected in brain (at protein level). Widely expressed, with highest levels in brain, heart and placenta.</text>
</comment>
<comment type="PTM">
<text evidence="5 6 9">Ubiquitinated; mediated by SIAH1, SIAH2 or RNF19A and leading to its subsequent proteasomal degradation. In the absence of proteasomal degradation, ubiquitinated SNCAIP accumulates in cytoplasmic inclusion bodies. Isoform 2 is subject to limited ubiquitination that does not lead to proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="7">
<disease id="DI-02134">
<name>Parkinson disease</name>
<acronym>PARK</acronym>
<description>A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.</description>
<dbReference type="MIM" id="168600"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Constructs encoding portions of SNCA and SNCAIP co-transfected in mammalian cells promote cytosolic inclusions resembling the Lewy bodies of Parkinson disease. Coexpression of SNCA, SNCAIP, and PARK2 result in the formation of Lewy body-like. ubiquitin-positive cytosolic inclusions. SNCAIP isoform 2 is particularly aggregation-prone. Familial mutations in PARK2 disrupt the ubiquitination of SNCAIP and the formation of the ubiquitin-positive inclusions. These results provide a molecular basis for the ubiquitination of Lewy body-associated proteins and link PARK2 and SNCA in a common pathogenic mechanism through their interaction with SNCAIP.</text>
</comment>
<comment type="similarity">
<text evidence="3">Contains 6 ANK repeats.</text>
</comment>
<dbReference type="EMBL" id="AF076929">
<property type="protein sequence ID" value="AAD30362.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167306">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167301">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167302">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167303">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167304">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167305">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ227317">
<property type="protein sequence ID" value="ABB51162.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471086">
<property type="protein sequence ID" value="EAW48889.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110788">
<property type="protein sequence ID" value="BAD19017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110789">
<property type="protein sequence ID" value="BAD19018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110790">
<property type="protein sequence ID" value="BAD19019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471086">
<property type="protein sequence ID" value="EAW48890.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033743">
<property type="protein sequence ID" value="AAH33743.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040552">
<property type="protein sequence ID" value="AAH40552.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC094759">
<property type="protein sequence ID" value="AAH94759.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4131.1">
<molecule id="Q9Y6H5-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58964.1">
<molecule id="Q9Y6H5-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78054.1">
<molecule id="Q9Y6H5-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001229864.1">
<molecule id="Q9Y6H5-2"/>
<property type="nucleotide sequence ID" value="NM_001242935.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295029.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="NM_001308100.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295034.1">
<molecule id="Q9Y6H5-4"/>
<property type="nucleotide sequence ID" value="NM_001308105.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295035.1">
<property type="nucleotide sequence ID" value="NM_001308106.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295036.1">
<molecule id="Q9Y6H5-5"/>
<property type="nucleotide sequence ID" value="NM_001308107.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295037.1">
<property type="nucleotide sequence ID" value="NM_001308108.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295038.1">
<property type="nucleotide sequence ID" value="NM_001308109.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005451.2">
<molecule id="Q9Y6H5-1"/>
<property type="nucleotide sequence ID" value="NM_005460.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542038.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543736.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542039.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543737.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542040.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543738.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542041.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543739.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542043.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543741.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542044.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543742.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542045.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543743.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.426463"/>
<dbReference type="PDB" id="2KES">
<property type="method" value="NMR"/>
<property type="chains" value="A=512-557"/>
</dbReference>
<dbReference type="PDBsum" id="2KES"/>
<dbReference type="ProteinModelPortal" id="Q9Y6H5"/>
<dbReference type="SMR" id="Q9Y6H5">
<property type="residue range" value="320-557"/>
</dbReference>
<dbReference type="BioGrid" id="114986">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="DIP" id="DIP-61155N"/>
<dbReference type="IntAct" id="Q9Y6H5">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="MINT" id="MINT-1380209"/>
<dbReference type="STRING" id="9606.ENSP00000261368"/>
<dbReference type="ChEMBL" id="CHEMBL1926494"/>
<dbReference type="iPTMnet" id="Q9Y6H5"/>
<dbReference type="PhosphoSite" id="Q9Y6H5"/>
<dbReference type="BioMuta" id="SNCAIP"/>
<dbReference type="DMDM" id="205831000"/>
<dbReference type="PaxDb" id="Q9Y6H5"/>
<dbReference type="PRIDE" id="Q9Y6H5"/>
<dbReference type="Ensembl" id="ENST00000261367">
<molecule id="Q9Y6H5-3"/>
<property type="protein sequence ID" value="ENSP00000261367"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000261368">
<molecule id="Q9Y6H5-1"/>
<property type="protein sequence ID" value="ENSP00000261368"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000379538">
<molecule id="Q9Y6H5-2"/>
<property type="protein sequence ID" value="ENSP00000368854"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395469">
<molecule id="Q9Y6H5-6"/>
<property type="protein sequence ID" value="ENSP00000378852"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="GeneID" id="9627"/>
<dbReference type="KEGG" id="hsa:9627"/>
<dbReference type="UCSC" id="uc003ksw.1">
<molecule id="Q9Y6H5-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc003ksx.1">
<molecule id="Q9Y6H5-3"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc003ksy.1">
<molecule id="Q9Y6H5-2"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc003ksz.1">
<molecule id="Q9Y6H5-5"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9627"/>
<dbReference type="GeneCards" id="SNCAIP"/>
<dbReference type="GeneReviews" id="SNCAIP"/>
<dbReference type="H-InvDB" id="HIX0005121"/>
<dbReference type="H-InvDB" id="HIX0018508"/>
<dbReference type="HGNC" id="HGNC:11139">
<property type="gene designation" value="SNCAIP"/>
</dbReference>
<dbReference type="HPA" id="CAB022597"/>
<dbReference type="HPA" id="HPA003266"/>
<dbReference type="MIM" id="168600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603779">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6H5"/>
<dbReference type="PharmGKB" id="PA35987"/>
<dbReference type="eggNOG" id="KOG0504">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0666">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000001485"/>
<dbReference type="HOVERGEN" id="HBG061375"/>
<dbReference type="InParanoid" id="Q9Y6H5"/>
<dbReference type="KO" id="K04558"/>
<dbReference type="OMA" id="QWKSPDA"/>
<dbReference type="PhylomeDB" id="Q9Y6H5"/>
<dbReference type="TreeFam" id="TF329095"/>
<dbReference type="ChiTaRS" id="SNCAIP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y6H5"/>
<dbReference type="GeneWiki" id="SNCAIP"/>
<dbReference type="GenomeRNAi" id="9627"/>
<dbReference type="NextBio" id="36127"/>
<dbReference type="PMAP-CutDB" id="Q9Y6H5"/>
<dbReference type="PRO" id="PR:Q9Y6H5"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="Q9Y6H5"/>
<dbReference type="CleanEx" id="HS_SNCAIP"/>
<dbReference type="ExpressionAtlas" id="Q9Y6H5">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y6H5">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042734">
<property type="term" value="C:presynaptic membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008021">
<property type="term" value="C:synaptic vesicle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008219">
<property type="term" value="P:cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0042417">
<property type="term" value="P:dopamine metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0090083">
<property type="term" value="P:regulation of inclusion body assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046928">
<property type="term" value="P:regulation of neurotransmitter secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002110">
<property type="entry name" value="Ankyrin_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR020683">
<property type="entry name" value="Ankyrin_rpt-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032027">
<property type="entry name" value="SNCAIP_SNCA-bd"/>
</dbReference>
<dbReference type="Pfam" id="PF12796">
<property type="entry name" value="Ank_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF16700">
<property type="entry name" value="SNCAIP_SNCA_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00248">
<property type="entry name" value="ANK"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48403">
<property type="entry name" value="SSF48403"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50297">
<property type="entry name" value="ANK_REP_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50088">
<property type="entry name" value="ANK_REPEAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0040">ANK repeat</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Synphilin-1" id="PRO_0000067068">
<location>
<begin position="1"/>
<end position="919"/>
</location>
</feature>
<feature type="repeat" description="ANK 1">
<location>
<begin position="349"/>
<end position="380"/>
</location>
</feature>
<feature type="repeat" description="ANK 2">
<location>
<begin position="384"/>
<end position="413"/>
</location>
</feature>
<feature type="repeat" description="ANK 3">
<location>
<begin position="419"/>
<end position="448"/>
</location>
</feature>
<feature type="repeat" description="ANK 4">
<location>
<begin position="456"/>
<end position="485"/>
</location>
</feature>
<feature type="repeat" description="ANK 5">
<location>
<begin position="603"/>
<end position="632"/>
</location>
</feature>
<feature type="repeat" description="ANK 6">
<location>
<begin position="699"/>
<end position="729"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="2">
<location>
<begin position="515"/>
<end position="552"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_038839" evidence="15 16">
<location>
<begin position="1"/>
<end position="366"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_038840" evidence="15 17">
<original>S</original>
<variation>SDNRSQGNRLQKLGLEDTDREDAMGFGSHRAKLTVVAALGACHCPENE</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_038841" evidence="17">
<location>
<begin position="335"/>
<end position="394"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_038842" evidence="15 16">
<original>QHLTSLMGEDCLNERNTEKLTPAGLAIK</original>
<variation>MTYLIQSHHSRRSQNCAEDVIRKTKTDQ</variation>
<location>
<begin position="367"/>
<end position="394"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_038843" evidence="17">
<original>LVEYGANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKLTKQLKEQTVERVTLQN</original>
<variation>RLKIQGTWNGSETCLFTHHFSSYPPISSGLQCQGQEGVLFIPDQVGAATNKQVLFQNQLPETKSSY</variation>
<location>
<begin position="476"/>
<end position="541"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_038844" evidence="17">
<location>
<begin position="542"/>
<end position="919"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_038845" evidence="15 16">
<original>A</original>
<variation>EMYSSCINLSSNMLIEEHLCNDTRHNDINRKMKKSYSIKHIAEPESKELFL</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56285021." id="VAR_065358" evidence="4 11 14">
<original>V</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6867105." id="VAR_048312">
<original>E</original>
<variation>G</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with symptoms of Parkinson disease; unknown pathological significance; reduced number of cytoplasmic inclusions in cells expressing C-621 compared with cells expressing wild-type (wt) protein when subjected to proteasomal inhibition; C-621 transfected cells are more susceptible to staurosporine-induced cell death than cells expressin wt protein; dbSNP:rs28937592." id="VAR_025667" evidence="7 11">
<original>R</original>
<variation>C</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_065359" evidence="11">
<original>E</original>
<variation>Q</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with SIAH1 and formation of cytoplasmic inclusion bodies; when associated with N-81." evidence="9">
<original>V</original>
<variation>N</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with SIAH1 and formation of cytoplasmic inclusion bodies; when associated with N-79." evidence="9">
<original>P</original>
<variation>N</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="18">
<original>E</original>
<variation>G</variation>
<location>
<position position="614"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="18">
<original>A</original>
<variation>G</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH94759." ref="6" evidence="18">
<original>D</original>
<variation>G</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH33743." ref="6" evidence="18">
<original>S</original>
<variation>P</variation>
<location>
<position position="801"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH94759." ref="6" evidence="18">
<original>A</original>
<variation>E</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="512"/>
<end position="554"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KES"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00023"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10319874"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11590439"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750386"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12761037"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14506261"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15064394"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16595633"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18366718"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224863"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19762560"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16595633"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="919" mass="100409" checksum="55C5316F250D0480" modified="2008-07-22" version="2">
MEAPEYLDLDEIDFSDDISYSVTSLKTIPELCRRCDTQNEDRSVSSSSWNCGISTLITNT
QKPTGIADVYSKFRPVKRVSPLKHQPETLENNESDDQKNQKVVEYQKGGESDLGPQPQEL
GPGDGVGGPPGKSSEPSTSLGELEHYDLDMDEILDVPYIKSSQQLASFTKVTSEKRILGL
CTTINGLSGKACSTGSSESSSSNMAPFCVLSPVKSPHLRKASAVIHDQHKLSTEETEISP
PLVKCGSAYEPENQSKDFLNKTFSDPHGRKVEKTTPDCQLRAFHLQSSAAESKPEEQVSG
LNRTSSQGPEERSEYLKKVKSILNIVKEGQISLLPHLAADNLDKIHDENGNNLLHIAASQ
GHAECLQHLTSLMGEDCLNERNTEKLTPAGLAIKNGQLECVRWMVSETEAIAELSCSKDF
PSLIHYAGCYGQEKILLWLLQFMQEQGISLDEVDQDGNSAVHVASQHGYLGCIQTLVEYG
ANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKLTKQLKEQTVERVTLQ
NQLQQFLEAQKSEGKSLPSSPSSPSSPASRKSQWKSPDADDDSVAKSKPGVQEGIQVLGS
LSASSRARPKAKDEDSDKILRQLLGKEISENVCTQEKLSLEFQDAQASSRNSKKIPLEKR
ELKLARLRQLMQRSLSESDTDSNNSEDPKTTPVRKADRPRPQPIVESVESMDSAESLHLM
IKKHTLASGGRRFPFSIKASKSLDGHSPSPTSESSEPDLESQYPGSGSIPPNQPSGDPQQ
PSPDSTAAQKVATSPKSALKSPSSKRRTSQNLKLRVTFEEPVVQMEQPSLELNGEKDKDK
GRTLQRTSTSNESGDQLKRPFGAFRSIMETLSGNQNNNNNYQAANQLKTSTLPLTSLGRK
TDAKGNPASSASKGKNKAA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>